Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ACAN "AGC1, CSPG1, CSPGCP, MSK16" ENSG00000157766 Aggrecan 15 88803442-88875354 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 28 "Extravillous trophoblasts: 120.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "WM-115: 22.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB016377, HPA038241, HPA038242" Enhanced "Secreted to extracellular matrix" NA NA "CAB016377: AB_626650, HPA038241: AB_2675909, HPA038242: AB_2675910" "unprognostic (2.69e-3)" "unprognostic (4.09e-2)" "unprognostic (2.52e-1)" "unprognostic (1.82e-1)" "unprognostic (4.43e-2)" "unprognostic (2.13e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-1)" "unprognostic (7.12e-2)" "unprognostic (8.57e-2)" "unprognostic (2.34e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (7.79e-2)" "unprognostic (1.53e-1)" "unprognostic (7.71e-2)" "unprognostic (7.27e-2)" 5.0 1.2 2.7 3.2 4.6 0.8 0.9 0.6 6.6 9.2 1.6 3.4 0.1 0.9 5.3 3.9 1.0 1.4 3.0 6.5 2.0 6.2 6.3 0.8 4.2 0.8 2.5 0.9 2.2 1.2 0.6 2.1 1.9 3.7 2.4 1.7 1.1 1.1 11.2 1.8 1.5 0.8 2.1 5.7 1.3 1.2 4.9 2.3 0.0 1.9 1.8 0.6 5.9 4.4 0.2 0.3 1.5 0.4 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 4.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 1.5 0.2 0.2 0.3 0.4 0.2 0.0 0.1 0.2 0.1 0.2 0.2 0.2 0.6 0.5 0.1 0.3 0.2 0.1 2.7 4.6 0.6 6.6 2.0 6.2 2.5 0.9 3.7 2.3 0.0 0.0 0.0 0.4 0.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 120.0 0.8 0.2 1.1 0.0 2.3 0.0 0.0 0.0 0.0 1.9 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.3 2.8 0.4 3.0 0.0 0.0 0.3 ADAMTSL5 THSD6 ENSG00000185761 "ADAMTS like 5" 19 1505018-1513604 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 19.3" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 8.1;Leydig cells: 17.8;Peritubular cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 16.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044050 Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA "Golgi apparatus" "HPA044050: AB_10962625" "unprognostic (1.71e-1)" "unprognostic (1.32e-1)" "unprognostic (5.85e-2)" "unprognostic (2.45e-1)" "unprognostic (1.10e-2)" "unprognostic (1.44e-1)" "unprognostic (1.17e-2)" "unprognostic (1.77e-2)" "unprognostic (1.89e-1)" "unprognostic (2.79e-2)" "unprognostic (2.89e-3)" "unprognostic (1.52e-1)" "unprognostic (5.03e-2)" "unprognostic (1.18e-1)" "unprognostic (3.04e-2)" "unprognostic (1.44e-1)" "unprognostic (2.37e-3)" 1.0 1.0 1.2 1.7 1.5 0.0 1.5 1.3 1.2 19.3 5.0 0.5 2.2 7.8 14.4 6.2 7.0 2.7 2.3 13.5 1.9 0.8 0.9 2.8 1.4 0.2 0.9 0.2 1.7 0.9 0.0 1.5 5.2 1.8 4.0 0.7 8.6 4.0 3.9 10.5 1.0 10.0 9.9 0.8 0.8 1.0 3.7 0.3 0.0 1.0 8.1 5.1 1.6 7.2 0.2 0.1 0.8 1.8 0.1 4.7 1.1 6.4 2.9 0.1 0.2 3.4 2.5 3.1 11.9 8.1 4.6 6.8 16.4 3.2 0.0 3.0 9.9 1.3 5.5 2.9 3.5 3.4 6.2 0.4 1.2 8.5 3.0 3.9 0.2 8.5 1.5 3.7 1.1 2.9 6.1 0.0 2.2 3.8 8.2 0.4 6.0 0.3 0.4 0.1 1.9 1.6 0.2 0.6 1.6 3.6 0.0 0.2 0.4 2.8 0.3 3.3 1.6 7.5 2.4 0.8 0.0 4.5 9.1 0.5 5.1 3.2 0.8 0.1 0.6 2.0 0.4 0.1 0.8 3.4 1.1 2.2 0.1 3.7 2.5 0.1 0.2 4.7 3.2 0.2 0.1 1.8 0.1 1.1 1.1 1.2 1.5 1.3 1.2 1.9 0.8 0.9 0.2 1.8 0.3 0.0 0.6 0.0 2.2 0.3 0.2 8.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.5 0.0 1.7 0.0 1.5 1.9 5.4 0.7 0.0 1.6 0.2 0.0 0.0 0.0 0.0 2.2 17.8 0.2 1.7 0.0 1.0 3.4 4.3 0.8 17.0 0.3 2.0 0.0 3.5 0.5 1.4 0.4 0.6 0.5 0.6 3.0 BGN "DSPG1, SLRR1A" ENSG00000182492 Biglycan P21810 X 153494939-153509554 "Disease related genes, Predicted secreted proteins" "Aortic aneurysm, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Peritubular cells: 735.8;Sertoli cells: 1461.7;Smooth muscle cells: 411.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 46.6;BJ hTERT+: 60.2;fHDF/TERT166: 84.0;HSkMC: 44.1;hTEC/SVTERT24-B: 35.7;HUVEC TERT2: 84.3;U-138 MG: 38.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003157, CAB003678" Enhanced Approved "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" NA NA 2500000 "Golgi apparatus" "Endoplasmic reticulum" "CAB003678: AB_425325, HPA003157: AB_1078282" "unprognostic (1.74e-1)" "unprognostic (2.49e-1)" "unprognostic (7.11e-3)" "unprognostic (3.60e-1)" "unprognostic (5.42e-2)" "unprognostic (3.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.22e-2)" "unprognostic (1.76e-3)" "unprognostic (1.30e-2)" "unprognostic (2.63e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (6.00e-8)" "unprognostic (7.05e-3)" "unprognostic (2.40e-2)" "unprognostic (5.66e-2)" "unprognostic (2.57e-3)" 41.1 39.7 8.1 23.2 14.6 0.4 20.2 5.6 14.3 76.7 12.0 18.7 16.7 6.0 63.4 31.7 21.1 23.6 86.7 133.0 8.9 5.2 67.6 78.1 77.6 29.4 8.9 16.3 39.6 16.8 5.1 26.7 131.1 15.0 33.6 7.0 48.3 20.4 38.2 17.0 31.0 8.6 56.9 5.9 101.3 10.0 28.0 15.8 3.9 45.3 29.9 14.6 34.5 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 4.9 11.0 0.1 46.6 60.2 8.6 2.8 5.8 0.0 0.0 8.6 84.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 4.2 0.0 0.0 44.1 0.3 35.7 1.6 4.4 84.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.8 0.1 0.0 17.8 38.3 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 14.6 5.6 14.3 8.9 5.2 8.9 16.3 15.0 15.8 3.0 9.3 0.0 1.0 92.5 0.0 6.7 5.1 2.7 4.5 8.7 0.0 13.9 1.7 2.4 1.4 48.7 0.0 0.0 0.2 33.9 142.9 2.3 3.5 1.0 4.0 3.2 0.0 198.2 3.1 4.0 137.0 6.2 33.7 3.6 0.0 0.0 1.8 0.0 735.8 0.3 0.1 1461.7 411.6 0.6 1.1 47.3 47.6 4.9 0.0 1.4 BMPER "CRIM3, Cv2" ENSG00000164619 "BMP binding endothelial regulator" Q8N8U9 7 33904911-34155872 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 17 "Ito cells: 97.6" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 11.8;BJ: 11.2;fHDF/TERT166: 14.5;HBF TERT88: 15.9;HSkMC: 11.9;hTEC/SVTERT24-B: 10.6;U-138 MG: 16.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "unprognostic (4.50e-2)" "unprognostic (2.68e-1)" "unprognostic (2.83e-2)" "unprognostic (3.19e-2)" "unprognostic (1.93e-1)" "unprognostic (1.96e-4)" "unprognostic (5.34e-3)" "unprognostic (3.10e-1)" "unprognostic (9.98e-3)" "unprognostic (3.50e-3)" "unprognostic (8.01e-4)" "unprognostic (1.96e-1)" "unprognostic (5.67e-5)" "unprognostic (2.54e-1)" "unprognostic (2.62e-1)" "unprognostic (2.06e-2)" "unprognostic (3.47e-3)" 7.0 1.1 2.2 8.5 6.3 0.3 2.2 9.5 9.7 5.0 2.4 0.6 0.0 1.3 3.4 6.7 1.6 1.6 2.0 2.7 2.4 1.9 1.1 12.9 5.7 7.8 1.6 4.7 3.3 1.0 0.4 5.3 11.3 6.0 9.5 2.0 1.8 1.9 0.9 3.7 1.0 3.8 2.0 1.7 1.0 4.2 1.4 0.0 0.0 1.1 2.0 0.3 1.6 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 11.8 6.3 0.0 11.2 2.8 7.1 6.2 0.0 0.0 0.1 0.0 14.5 3.9 5.3 0.0 0.0 15.9 0.0 0.5 0.0 0.5 0.0 1.2 0.0 0.0 11.9 0.0 10.6 0.0 0.6 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 2.1 0.9 0.0 0.0 16.6 1.4 8.2 0.0 1.4 0.0 0.0 6.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 6.3 9.5 9.7 2.4 1.9 1.6 4.7 6.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 4.2 0.0 0.0 0.0 0.0 5.9 0.4 0.0 0.1 1.5 0.6 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 4.1 97.6 4.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.3 0.0 0.8 0.0 3.9 0.1 0.1 0.0 0.0 0.2 CCDC80 "DRO1, SSG1, URB" ENSG00000091986 "Coiled-coil domain containing 80" Q76M96 3 112596794-112649530 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 130.0;endometrium 1: 143.8" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 452.4;Fibroblasts: 524.3;Late spermatids: 232.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 48.6;fHDF/TERT166: 113.6;hTERT-RPE1: 221.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA002266 Approved "Secreted to extracellular matrix" NA NA 57000 "HPA002266: AB_1078423" "unprognostic (1.26e-1)" "unprognostic (1.89e-1)" "unprognostic (1.26e-2)" "unprognostic (3.19e-1)" "unprognostic (2.29e-1)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (2.53e-2)" "unprognostic (2.30e-3)" "unprognostic (1.99e-3)" "unprognostic (8.40e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (2.86e-5)" "unprognostic (5.97e-3)" "unprognostic (1.65e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.26e-4)" 49.5 3.3 1.4 16.4 3.1 0.0 39.4 3.1 3.3 130.0 14.9 3.4 54.7 1.1 143.8 94.7 34.2 17.4 39.7 87.6 2.3 2.8 10.7 2.1 17.0 10.1 3.0 1.0 53.3 6.6 2.5 2.7 6.0 7.2 28.6 12.7 8.7 8.7 21.7 4.1 19.2 8.6 81.3 14.0 19.8 12.0 14.0 3.3 4.1 20.4 29.6 10.8 57.3 33.8 2.9 3.0 2.9 1.3 1.3 2.1 0.2 2.2 0.9 11.6 0.5 48.6 38.7 0.6 32.1 9.7 10.8 15.8 0.2 0.1 0.1 1.2 113.6 1.0 3.0 0.4 0.4 11.4 2.1 0.1 0.0 2.6 0.0 10.2 0.0 0.0 38.2 1.3 15.9 1.0 221.6 2.5 0.0 0.0 0.1 31.8 0.0 0.0 0.0 2.8 0.0 0.3 0.0 1.2 0.0 0.3 0.0 0.0 0.2 4.7 0.2 0.1 2.2 0.1 0.0 12.6 31.8 5.2 6.0 13.9 0.1 0.0 0.1 9.4 0.0 5.1 2.9 1.3 0.9 1.6 0.8 1.6 1.7 1.6 1.3 0.5 2.9 2.1 1.9 1.7 1.3 0.8 3.0 1.1 0.2 1.4 3.1 3.1 1.7 2.3 2.8 3.0 1.0 7.2 3.3 6.0 12.8 0.0 3.8 54.1 0.6 19.6 0.0 33.5 9.1 5.2 0.0 40.0 1.7 22.1 452.4 12.8 0.0 0.0 1.1 85.3 524.3 1.2 1.1 0.5 8.3 0.0 0.0 56.4 2.7 232.6 71.4 5.8 136.7 3.6 0.4 119.7 10.8 0.0 32.5 0.0 1.7 19.4 127.8 6.0 3.2 45.2 23.3 0.0 0.0 1.7 CHAD SLRR4A ENSG00000136457 Chondroadherin O15335 17 50464496-50468966 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 2.5;Enterocytes: 2.0;Hepatocytes: 2.4;Mucus-secreting cells: 2.2" "Cancer enhanced" "Detected in many" "breast cancer: 23.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 52 "memory B-cell: 17.9;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 83 "B-cells: 17.9" "Cell line enhanced" "Detected in many" "RT4: 6.3;SCLC-21H: 13.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA018241 Enhanced "Secreted to extracellular matrix" NA NA 15000000 "HPA018241: AB_1846612" "prognostic favorable (7.68e-4)" "unprognostic (4.34e-2)" "unprognostic (1.24e-1)" "unprognostic (9.67e-3)" "unprognostic (1.92e-1)" "unprognostic (3.06e-3)" "prognostic favorable (1.59e-4)" "unprognostic (1.51e-2)" "unprognostic (4.75e-2)" "unprognostic (3.73e-3)" "unprognostic (1.53e-1)" "unprognostic (1.39e-1)" "unprognostic (1.92e-1)" "unprognostic (2.52e-1)" "unprognostic (1.84e-2)" "unprognostic (1.51e-3)" "unprognostic (1.41e-3)" 4.5 10.0 11.3 0.8 10.9 0.4 9.5 19.2 8.5 21.0 3.2 4.2 0.1 7.7 0.7 0.9 1.8 0.4 1.5 1.0 11.6 2.7 1.5 18.4 3.7 0.7 2.2 2.9 3.0 17.9 0.1 0.8 0.6 4.9 1.0 3.7 0.3 9.0 0.4 15.4 8.1 9.1 0.2 5.0 1.2 4.7 2.0 3.5 0.6 2.5 3.4 20.6 0.8 0.5 17.9 0.1 0.0 0.0 0.0 0.2 0.5 1.5 1.1 1.1 1.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 2.3 1.2 0.1 0.4 0.0 0.3 2.3 0.0 0.0 0.0 0.9 1.2 1.8 0.9 2.1 0.0 0.6 1.8 0.0 0.0 0.0 0.0 2.8 0.0 0.7 0.2 0.4 0.0 0.7 0.0 1.1 0.1 0.2 1.2 1.4 0.2 2.4 0.0 6.3 13.1 0.5 0.2 0.5 0.0 0.5 0.6 0.3 1.4 3.5 0.7 0.2 0.0 2.5 0.0 0.1 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.2 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 11.3 10.9 19.2 8.5 11.6 2.7 2.2 2.9 4.9 3.5 0.0 0.0 0.0 0.1 0.2 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.6 0.3 CHADL SLRR4B ENSG00000100399 "Chondroadherin like" Q6NUI6 22 41229510-41240934 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 45.8;salivary gland: 14.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 19.4;Melanocytes: 16.9;Muller glia cells: 37.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 16.2;Hep G2: 4.4;hTCEpi: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA005696, HPA024654" Uncertain "Secreted to extracellular matrix" NA NA "HPA005696: AB_1079724, HPA024654: AB_1846615" "unprognostic (6.14e-2)" "unprognostic (4.42e-3)" "unprognostic (1.49e-1)" "unprognostic (6.45e-3)" "unprognostic (1.32e-1)" "unprognostic (9.51e-3)" "unprognostic (2.20e-2)" "prognostic favorable (1.56e-4)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (2.83e-3)" "unprognostic (1.51e-2)" "unprognostic (4.67e-8)" "unprognostic (8.36e-3)" "unprognostic (4.10e-1)" "unprognostic (3.40e-1)" "unprognostic (4.09e-2)" 3.2 6.3 8.6 0.7 20.3 1.2 2.4 2.7 22.4 2.8 4.1 45.8 0.4 2.0 1.5 2.1 4.3 3.1 3.4 6.9 12.7 9.8 1.3 1.7 2.8 1.0 18.6 10.1 2.8 4.5 0.5 1.7 0.9 17.2 4.6 0.5 7.3 14.2 5.3 2.6 7.0 1.8 1.2 39.8 1.0 3.3 2.0 20.3 0.0 4.0 0.2 0.6 1.8 1.3 0.3 4.2 1.6 1.4 0.0 1.6 1.2 0.8 0.3 0.3 0.4 0.2 0.1 16.2 0.6 0.0 0.1 0.3 0.2 0.1 0.2 0.1 0.9 0.1 0.7 0.0 0.9 0.0 0.2 0.3 0.0 0.4 4.4 0.5 0.2 0.1 1.5 4.6 0.4 0.0 0.1 0.5 0.3 0.1 0.6 0.0 0.4 0.2 0.7 0.4 0.4 0.6 0.2 0.7 0.2 0.3 0.4 1.0 0.2 1.7 0.3 0.2 0.1 0.1 1.6 0.3 0.2 0.2 0.2 0.1 0.3 0.2 0.1 0.3 0.2 2.1 0.0 0.6 1.6 0.7 1.4 0.9 0.0 0.6 1.0 0.5 0.3 1.6 0.7 0.7 0.0 0.2 4.2 0.1 1.2 8.6 20.3 2.7 15.2 12.7 9.8 18.6 10.1 17.2 20.3 6.0 2.1 0.0 7.2 3.5 1.9 2.6 2.5 5.3 1.2 3.5 0.0 2.1 6.6 1.6 19.4 1.0 0.5 0.0 1.0 5.2 2.1 4.6 0.0 2.4 4.1 0.0 2.9 1.8 0.0 6.2 3.4 0.8 16.9 0.0 0.6 37.9 1.0 0.0 2.8 4.2 1.3 0.0 0.5 0.4 1.1 3.1 1.3 0.0 1.2 4.3 CILP HsT18872 ENSG00000138615 "Cartilage intermediate layer protein" O75339 15 65194758-65211488 "Disease related genes, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 12 "Leydig cells: 214.3;Peritubular cells: 54.1" "Cancer enhanced" "Detected in many" "breast cancer: 30.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 7.2;ASC TERT1: 4.4;EFO-21: 1.9;HSkMC: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA003195 Uncertain "Secreted to extracellular matrix" NA NA 11000000 "HPA003195: AB_1078524" "unprognostic (2.21e-2)" "unprognostic (3.43e-2)" "unprognostic (4.22e-2)" "unprognostic (7.18e-2)" "unprognostic (2.94e-1)" "unprognostic (2.28e-1)" "unprognostic (2.60e-1)" "unprognostic (1.14e-1)" "unprognostic (1.88e-2)" "unprognostic (3.00e-2)" "unprognostic (1.84e-1)" "unprognostic (1.27e-1)" "unprognostic (2.31e-13)" "unprognostic (5.10e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (4.68e-3)" 32.0 0.4 0.0 8.1 0.1 0.0 17.0 0.4 0.0 39.9 11.1 0.1 12.7 1.2 9.2 44.7 21.4 10.5 19.6 16.5 0.0 0.0 0.5 1.0 1.8 1.4 0.2 0.0 9.6 2.4 0.1 0.4 3.0 0.1 13.3 3.9 0.6 5.6 5.1 19.7 8.4 12.5 41.6 0.3 0.3 5.4 18.4 0.0 1.4 2.0 23.4 3.1 41.4 17.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 7.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.1 11.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.6 0.6 1.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 2.4 214.3 0.0 1.7 0.0 0.0 0.3 0.0 0.0 54.1 0.0 0.0 0.0 3.8 0.6 0.2 5.4 0.0 0.0 0.0 0.0 CILP2 MGC45771 ENSG00000160161 "Cartilage intermediate layer protein 2" Q8IUL8 19 19538248-19546659 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 9.4;testis: 10.1" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 20.5;Late spermatids: 15.9;Sertoli cells: 6.5;Spermatogonia: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "naive CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "ASC diff: 8.9;HEK 293: 5.2;NB-4: 3.9;THP-1: 5.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA041847 Uncertain "Secreted to extracellular matrix" NA NA 11000000 "HPA041847: AB_10795599" "unprognostic (6.51e-2)" "unprognostic (2.54e-2)" "unprognostic (5.42e-4)" "prognostic unfavorable (3.22e-6)" "unprognostic (4.81e-2)" "unprognostic (1.73e-1)" "unprognostic (4.31e-2)" "unprognostic (4.13e-3)" "unprognostic (4.48e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (5.09e-2)" "unprognostic (1.41e-2)" "unprognostic (0.00e+0)" "unprognostic (1.59e-2)" "unprognostic (3.19e-2)" "unprognostic (3.12e-3)" "unprognostic (1.36e-2)" 2.8 0.1 0.9 1.1 1.0 3.1 3.6 0.3 1.1 3.1 0.7 0.0 0.8 0.1 0.7 1.1 0.8 0.9 5.6 1.0 0.8 1.4 0.2 0.7 0.9 2.5 0.3 0.0 9.4 0.2 1.4 0.9 2.4 0.4 1.2 0.2 3.0 2.8 0.9 4.0 0.7 0.3 0.5 0.1 0.7 0.2 10.1 0.0 0.0 7.8 0.4 1.8 1.1 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 0.3 0.2 8.9 0.3 1.2 1.1 0.0 0.5 0.1 2.4 0.9 0.1 2.3 0.4 0.1 1.0 0.2 0.0 0.1 0.6 5.2 0.0 0.2 0.3 0.3 0.0 0.6 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.0 3.9 3.3 2.7 1.6 0.6 0.0 0.0 0.1 0.0 0.1 2.2 0.5 2.8 0.3 0.5 0.5 5.0 0.0 0.1 1.1 0.4 0.2 0.7 2.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.3 1.1 0.8 1.4 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.5 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.3 3.7 4.5 0.5 0.0 0.0 0.0 0.4 CLEC3A CLECSF1 ENSG00000166509 "C-type lectin domain family 3 member A" 16 78022515-78066761 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 14.6;prostate: 8.6;smooth muscle: 17.1;urinary bladder: 17.2" "Cell type enhanced" "Detected in single" 26 "Glandular cells: 1.4" "Cancer enriched" "Detected in some" 102 "breast cancer: 78.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SK-BR-3: 7.5;T-47d: 21.4" "Region enhanced" "Detected in single" "midbrain: 0.5" "Not detected" "Not detected" HPA051511 Uncertain "Secreted to extracellular matrix" NA NA "HPA051511: AB_2681514" "prognostic unfavorable (1.61e-4)" "unprognostic (1.60e-1)" "unprognostic (2.42e-1)" "unprognostic (1.25e-1)" "unprognostic (4.95e-2)" "unprognostic (3.80e-2)" 0.1 0.1 0.1 1.8 0.3 0.0 14.6 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 4.6 0.3 0.1 1.1 0.1 0.1 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.4 8.6 0.0 3.3 0.1 0.0 0.1 0.1 0.1 17.1 0.1 0.1 0.8 0.1 0.0 0.0 0.1 1.9 0.0 17.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.8 0.1 1.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COL10A1 ENSG00000123500 "Collagen type X alpha 1 chain" Q03692 6 116118923-116158747 "Disease related genes, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 12.2;retina: 32.7" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 1.1;Club cells: 1.2;Horizontal cells: 1.6;Muller glia cells: 2.0" "Cancer enhanced" "Detected in many" "pancreatic cancer: 51.9" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.7" "Cell line enriched" "Detected in some" 6 "hTEC/SVTERT24-B: 30.1" "Region enhanced" "Detected in single" "amygdala: 1.0" "Low region specificity" "Detected in single" HPA053268 Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 21000 "Endoplasmic reticulum" "HPA053268: " "unprognostic (3.83e-2)" "unprognostic (6.81e-2)" "unprognostic (7.20e-2)" "unprognostic (7.45e-3)" "unprognostic (2.33e-2)" "unprognostic (1.28e-1)" "unprognostic (3.84e-2)" "unprognostic (1.49e-1)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" "unprognostic (4.37e-2)" "unprognostic (7.03e-2)" "unprognostic (1.38e-11)" "unprognostic (2.16e-3)" "unprognostic (7.22e-2)" "unprognostic (3.60e-1)" "unprognostic (2.06e-3)" 0.9 0.1 0.4 0.8 0.7 0.1 0.3 0.3 1.4 1.4 0.3 0.9 0.3 0.0 0.6 0.3 0.5 0.0 12.2 0.3 0.6 0.2 0.8 0.7 3.5 0.4 0.3 0.6 5.4 4.2 0.5 0.9 0.3 3.2 2.6 0.0 32.7 6.5 0.9 0.3 0.7 0.3 0.5 0.3 2.9 0.2 0.5 0.3 0.8 1.4 0.3 2.0 0.3 0.3 0.6 0.3 2.7 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 2.2 0.3 4.6 0.0 0.0 0.1 0.0 0.7 0.0 0.5 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 30.1 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 4.9 0.1 0.3 0.4 0.0 0.0 0.1 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.3 0.4 0.7 0.3 1.4 0.6 0.2 0.3 0.6 3.2 0.3 0.0 1.1 0.0 0.0 0.1 0.7 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 COL11A1 "CO11A1, COLL6, STL2" ENSG00000060718 "Collagen type XI alpha 1 chain" P12107 1 102876467-103108872 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 33.3" "Group enriched" "Detected in some" 7 "Early spermatids: 12.1;Melanocytes: 10.1;Muller glia cells: 27.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 38.5;BJ: 13.5;BJ hTERT+ SV40 Large T+ RasG12V: 28.8;HBF TERT88: 16.3;HSkMC: 48.5;SuSa: 21.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA058335 Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" No No 270000 "Endoplasmic reticulum" "HPA058335: AB_2683682" "unprognostic (2.60e-3)" "unprognostic (6.61e-4)" "unprognostic (9.58e-2)" "unprognostic (5.06e-5)" "unprognostic (2.83e-1)" "unprognostic (2.85e-2)" "unprognostic (6.03e-3)" "unprognostic (2.23e-3)" "unprognostic (9.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-2)" "unprognostic (1.94e-2)" "unprognostic (3.01e-12)" "unprognostic (1.27e-2)" "unprognostic (3.53e-1)" "unprognostic (3.54e-2)" "unprognostic (2.32e-2)" 1.2 1.8 8.6 1.3 9.1 0.8 1.5 2.0 7.9 2.3 1.1 4.1 0.0 1.0 1.8 1.0 0.8 0.8 5.9 0.8 8.3 8.6 1.0 0.8 1.2 0.9 8.1 5.9 1.2 1.9 1.0 5.5 33.3 11.1 1.1 1.4 5.9 3.3 2.2 0.9 2.4 0.9 1.3 9.0 2.2 0.9 4.7 5.8 0.0 0.9 0.6 0.8 1.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 38.5 0.0 1.5 2.1 0.0 13.5 5.2 7.8 28.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 48.5 0.0 0.3 0.0 5.9 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 2.4 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.2 9.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.6 9.1 2.0 7.9 8.3 8.6 8.1 5.9 11.1 5.8 0.0 2.1 0.0 0.0 1.5 0.6 0.4 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.5 2.1 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.9 1.1 0.6 10.1 0.0 0.0 27.8 0.1 0.0 0.0 0.0 1.7 0.0 1.9 0.5 0.4 1.0 0.2 0.0 0.0 0.0 COL11A2 "DFNA13, DFNB53, HKE5" ENSG00000204248 "Collagen type XI alpha 2 chain" P13942 6 33162681-33192499 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Deafness, Disease mutation, Dwarfism, Non-syndromic deafness, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "pituitary gland: 28.8" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 3.9;Early spermatids: 11.3;Ito cells: 6.7;Muller glia cells: 6.7" "Cancer enriched" "Detected in many" 8 "melanoma: 13.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;HMC-1: 2.1;U-266/70: 2.4;U-698: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" NA NA 720000 "unprognostic (4.62e-1)" "unprognostic (8.69e-2)" "unprognostic (1.65e-4)" "unprognostic (5.15e-3)" "unprognostic (1.14e-1)" "unprognostic (1.69e-1)" "unprognostic (1.04e-2)" "unprognostic (9.67e-2)" "unprognostic (2.05e-2)" "unprognostic (4.47e-2)" "unprognostic (1.22e-1)" "unprognostic (3.41e-3)" "unprognostic (2.26e-6)" "unprognostic (8.27e-2)" "unprognostic (2.17e-1)" "unprognostic (1.88e-1)" "unprognostic (5.96e-2)" 1.6 0.7 0.8 0.6 1.5 0.2 0.4 6.6 2.8 1.2 0.4 2.5 0.1 1.2 0.6 1.2 0.4 0.3 0.5 1.6 1.1 0.9 0.4 0.8 0.7 0.3 2.7 0.1 0.5 1.7 0.2 28.8 0.5 1.7 0.8 0.2 2.6 2.2 0.6 2.5 1.6 1.5 0.9 2.2 0.8 3.5 4.5 1.8 1.1 2.1 0.9 0.6 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.1 0.2 0.1 2.0 0.3 1.6 1.0 0.2 0.7 0.2 0.0 0.0 0.5 0.3 0.2 0.4 0.0 0.0 0.0 0.3 2.1 0.3 0.0 0.1 0.1 0.0 0.1 1.5 0.5 0.8 0.2 0.3 0.0 0.6 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 1.4 0.2 1.2 0.4 0.2 0.8 1.5 0.0 0.1 2.4 1.7 2.9 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.4 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.8 1.5 6.6 1.2 1.1 0.9 2.7 0.1 1.7 1.8 0.0 0.0 0.0 0.1 1.3 1.9 2.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 11.3 0.7 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 6.7 1.2 1.0 0.0 0.0 1.7 0.0 0.0 6.7 0.1 0.0 0.4 0.0 1.1 0.0 1.0 0.9 1.5 1.0 0.0 0.0 0.0 0.0 COL17A1 "BP180, BPAG2" ENSG00000065618 "Collagen type XVII alpha 1 chain" Q9UMD9 10 104031286-104086002 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 85.8;skin 1: 123.2;tongue: 64.0" "Cell type enriched" "Detected in many" 4 "Basal keratinocytes: 520.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 227.4" "Region enriched" "Detected in single" 4 "basal ganglia: 1.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 3.7" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 24.8;HaCaT: 56.6;HBEC3-KT: 90.6;hTCEpi: 117.8;hTERT-HME1: 100.3" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Not detected" "Not detected" "HPA043673, HPA052963" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" "Golgi apparatus" "HPA043673: AB_10960893, HPA052963: AB_2681999" "prognostic favorable (1.38e-4)" "unprognostic (1.33e-1)" "unprognostic (4.01e-1)" "unprognostic (1.01e-1)" "unprognostic (9.65e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (6.82e-3)" "unprognostic (1.63e-1)" "unprognostic (7.85e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.75e-2)" "unprognostic (8.35e-2)" 0.2 0.0 0.2 4.4 1.2 7.5 8.1 0.2 0.2 15.2 9.3 0.2 0.9 2.0 0.6 2.6 31.5 0.1 1.2 0.2 0.2 0.1 0.4 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.0 0.6 85.8 0.2 5.0 5.4 0.2 15.5 7.3 0.5 123.2 23.2 0.8 0.2 0.3 3.9 4.0 0.2 18.1 2.0 64.0 24.7 3.0 17.3 0.0 0.0 3.7 0.2 0.0 0.0 0.8 3.1 0.0 0.1 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.7 0.0 0.5 56.6 0.1 90.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.8 0.0 100.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 5.1 3.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.0 0.8 0.2 1.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.6 0.0 12.4 520.3 0.6 0.8 0.0 2.7 20.5 0.0 0.0 3.5 0.0 0.7 8.5 1.0 105.8 0.0 0.8 8.3 2.1 0.6 0.0 0.0 1.2 0.0 2.4 0.0 0.0 2.6 0.3 1.0 32.1 0.0 5.9 0.4 45.8 16.1 0.7 0.0 0.4 0.0 1.7 8.3 1.1 121.8 4.7 0.0 14.5 8.0 COL1A1 OI4 ENSG00000108821 "Collagen type I alpha 1 chain" P02452 17 50183289-50201632 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 415.7" "Cell type enhanced" "Detected in many" 22 "Fibroblasts: 2038.6;Ito cells: 615.0;Leydig cells: 514.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 5 "T-cells: 1.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 91.8;BJ: 176.2;fHDF/TERT166: 266.1;HHSteC: 71.8;HSkMC: 134.8;U-138 MG: 143.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA011795, HPA012111" Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA 58000000 "Endoplasmic reticulum, Vesicles" "HPA011795: AB_1847088, HPA012111: " "unprognostic (1.61e-1)" "unprognostic (3.60e-3)" "unprognostic (8.29e-2)" "unprognostic (5.52e-2)" "unprognostic (7.74e-2)" "unprognostic (2.22e-1)" "unprognostic (6.01e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.23e-2)" "unprognostic (2.55e-2)" "unprognostic (8.53e-2)" "unprognostic (9.90e-2)" "prognostic unfavorable (7.19e-12)" "unprognostic (2.74e-2)" "unprognostic (4.73e-2)" "unprognostic (7.26e-2)" "unprognostic (3.87e-3)" 30.2 5.7 0.7 28.2 4.0 0.1 31.7 0.6 0.9 415.7 25.7 1.6 23.9 3.0 121.8 70.9 17.4 33.0 110.3 43.9 0.7 0.1 7.5 4.6 18.8 38.5 0.7 1.2 73.6 10.5 1.0 10.7 89.1 2.2 31.5 4.0 9.2 9.1 21.0 11.0 35.5 10.6 88.0 1.3 13.7 15.0 44.6 0.7 7.7 6.7 15.5 8.7 67.3 49.7 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.2 0.9 0.1 37.7 91.8 1.6 176.2 47.9 43.9 27.6 3.5 0.8 0.0 0.4 266.1 0.3 0.5 0.4 0.1 7.9 0.2 0.3 0.0 4.4 0.2 71.8 0.0 0.0 134.8 2.6 53.7 0.2 7.3 0.0 0.2 0.1 0.0 22.1 0.4 0.0 0.0 0.9 0.6 0.5 0.3 0.1 0.1 0.2 0.0 0.1 0.5 0.3 0.2 0.0 13.7 2.2 0.0 0.0 143.2 31.3 21.4 0.8 0.1 0.3 0.0 10.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.0 0.6 0.9 0.7 0.1 0.7 1.2 2.2 0.7 8.9 14.4 0.5 11.0 166.9 0.0 4.8 0.0 5.3 12.5 7.0 0.0 29.5 0.0 11.2 0.9 5.1 0.0 0.0 3.7 26.1 2038.6 12.1 2.3 1.9 59.9 0.0 2.9 615.0 0.8 4.5 514.8 7.7 178.8 0.0 2.2 2.8 25.7 0.0 252.1 0.5 0.1 77.6 273.4 4.2 1.7 142.9 93.5 0.5 1.3 7.5 COL1A2 OI4 ENSG00000164692 "Collagen type I alpha 2 chain" P08123 7 94394561-94431232 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 244.6" "Cell type enhanced" "Detected in many" 15 "Fibroblasts: 1445.8;Ito cells: 427.2;Leydig cells: 918.4;Peritubular cells: 470.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 154.3;ASC TERT1: 185.1;BJ: 151.4;BJ hTERT+: 111.2;fHDF/TERT166: 512.4;HSkMC: 160.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB032650, HPA059738" Approved Supported "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 21000000 "Endoplasmic reticulum" "CAB032650: AB_2082039, HPA059738: AB_2684116" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (1.32e-1)" "unprognostic (3.40e-2)" "unprognostic (2.86e-2)" "unprognostic (2.81e-1)" "unprognostic (5.15e-2)" "unprognostic (7.38e-3)" "unprognostic (2.01e-2)" "unprognostic (1.40e-2)" "unprognostic (5.83e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.51e-9)" "unprognostic (1.35e-2)" "unprognostic (5.25e-2)" "unprognostic (1.15e-1)" "unprognostic (3.31e-3)" 44.7 9.8 1.2 34.9 4.3 0.0 33.4 1.7 2.4 244.6 26.5 2.1 54.1 3.8 166.9 139.1 28.2 36.6 101.4 45.1 1.3 0.8 10.2 4.1 37.1 20.4 1.8 2.8 68.3 10.9 1.8 6.0 70.6 3.8 40.3 10.1 23.0 17.5 28.0 12.1 35.6 15.2 100.7 3.2 16.4 16.1 49.7 1.1 5.6 14.7 42.7 12.6 62.4 55.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 57.1 154.3 185.1 0.0 151.4 111.2 24.9 33.3 0.0 0.1 0.0 0.1 512.4 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 40.4 0.0 0.0 160.7 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.5 63.6 0.0 39.4 4.2 0.0 0.0 0.0 15.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.3 1.7 2.4 1.3 0.8 1.8 2.8 3.8 1.1 3.0 17.5 0.0 0.5 198.1 0.1 13.3 0.0 1.4 5.7 1.8 0.0 23.0 0.0 2.8 7.1 30.1 0.0 0.0 0.2 19.3 1445.8 1.2 9.3 1.1 95.1 0.0 0.0 427.2 1.0 22.0 918.4 12.0 226.0 4.6 0.0 3.0 8.5 0.0 470.9 0.3 0.3 297.5 291.6 5.1 3.2 163.7 59.2 0.0 0.0 0.7 COL20A1 KIAA1510 ENSG00000101203 "Collagen type XX alpha 1 chain" Q9P218 20 63293186-63334851 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 21.6" "Cell type enhanced" "Detected in some" 18 "Horizontal cells: 3.2;Late spermatids: 1.8;Spermatocytes: 8.1;Spermatogonia: 3.6" "Cancer enriched" "Detected in single" 19 "glioma: 8.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 1.6;SK-MEL-30: 3.3;SuSa: 1.5;U-266/70: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" NA NA "unprognostic (6.34e-4)" "unprognostic (2.52e-1)" "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "unprognostic (2.01e-1)" "unprognostic (5.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.45e-1)" "unprognostic (1.21e-1)" "unprognostic (1.70e-2)" "unprognostic (1.71e-1)" "unprognostic (2.89e-1)" "unprognostic (8.41e-7)" "unprognostic (7.85e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-2)" "unprognostic (1.16e-1)" 0.6 0.9 6.9 0.6 3.9 0.6 0.5 2.2 21.6 1.0 0.6 14.0 0.0 0.5 0.5 1.2 0.5 0.6 0.5 0.6 5.6 3.0 0.6 0.6 0.5 0.5 4.7 4.5 0.7 0.5 0.5 1.1 0.6 3.5 0.6 0.5 0.7 0.8 0.6 0.5 0.5 0.6 0.5 4.3 2.0 0.5 3.0 5.0 0.0 0.5 0.2 0.5 0.5 0.1 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.9 0.0 0.3 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.6 0.0 1.6 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 3.3 1.5 0.0 0.0 0.0 0.0 0.6 0.7 0.1 2.5 0.5 0.3 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 6.9 3.9 2.2 6.3 5.6 3.0 4.7 4.5 3.5 5.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 1.4 0.0 0.0 8.1 3.6 0.0 0.0 0.0 0.0 0.0 COL21A1 ENSG00000124749 "Collagen type XXI alpha 1 chain" Q96P44 6 56056590-56394094 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 36.4;Ciliated cells: 58.9;Extravillous trophoblasts: 52.2;Fibroblasts: 33.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC TERT1: 18.9;BEWO: 6.1;HSkMC: 19.2;SuSa: 9.3" HPA031212 Supported Cytosol "Secreted to extracellular matrix" NA NA 180000 Cytosol "HPA031212: AB_10599941" "unprognostic (1.69e-1)" "unprognostic (4.53e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-1)" "unprognostic (1.21e-1)" "unprognostic (9.32e-3)" "unprognostic (6.84e-2)" "unprognostic (9.04e-3)" "unprognostic (1.54e-3)" "unprognostic (2.17e-1)" "unprognostic (5.29e-2)" "unprognostic (3.10e-1)" "unprognostic (1.26e-3)" "unprognostic (3.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.27e-3)" 3.9 1.6 6.6 2.1 2.3 0.3 3.0 5.1 3.6 25.8 11.3 5.2 7.9 0.8 20.0 7.0 3.3 7.6 3.9 4.5 8.5 2.5 1.4 1.5 7.4 0.7 3.6 4.6 3.9 2.1 0.8 3.6 26.4 6.9 5.4 2.2 5.9 4.4 10.9 2.3 6.3 2.6 24.2 5.3 0.7 5.7 3.8 5.8 0.0 2.1 4.1 0.8 10.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.6 0.1 0.0 1.0 18.9 6.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.6 0.1 0.0 19.2 0.7 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.6 2.3 5.1 3.6 8.5 2.5 3.6 4.6 6.9 5.8 0.0 1.0 0.0 2.3 5.3 0.0 36.4 0.0 58.9 12.5 0.0 0.0 17.6 0.0 0.0 3.5 3.4 0.0 0.0 0.0 52.2 33.7 0.1 0.0 0.0 5.4 0.0 0.0 4.3 0.8 1.1 14.1 1.0 5.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 6.6 0.2 0.6 3.6 19.5 0.0 0.0 1.5 COL22A1 ENSG00000169436 "Collagen type XXII alpha 1 chain" Q8NFW1 8 138588235-138914006 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 46.5" "Group enriched" "Detected in some" 4 "Early spermatids: 30.8;Late spermatids: 25.2;Muller glia cells: 26.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 23.9;RT4: 10.2;SCLC-21H: 6.9;U-2 OS: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024830 Enhanced Supported "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA Vesicles "Endoplasmic reticulum" "HPA024830: AB_1847102" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (2.88e-2)" "unprognostic (4.19e-6)" "prognostic unfavorable (4.15e-4)" "unprognostic (1.05e-2)" "unprognostic (5.57e-3)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.01e-1)" "unprognostic (9.24e-2)" "unprognostic (5.74e-2)" "unprognostic (3.62e-2)" "unprognostic (3.66e-15)" "unprognostic (2.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (1.09e-1)" 0.1 12.0 0.2 1.3 1.1 0.0 0.1 6.8 1.1 1.3 0.7 1.4 10.8 0.3 2.4 1.9 0.2 0.5 0.4 0.2 0.3 0.8 2.8 0.1 0.1 0.5 0.3 0.0 0.3 0.2 1.7 46.5 0.0 1.9 4.7 0.1 1.6 0.8 5.1 0.5 0.1 0.4 2.2 1.8 0.3 3.7 0.8 0.1 1.4 0.3 0.7 1.7 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 10.2 6.9 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 6.8 0.3 0.3 0.8 0.3 0.0 1.9 0.1 0.0 0.0 0.0 2.8 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 30.8 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 6.2 0.0 0.0 0.0 0.0 25.2 0.3 0.0 0.0 1.0 0.0 26.2 2.1 0.0 0.0 0.0 1.1 0.0 0.3 1.1 0.8 0.0 0.0 0.0 0.0 1.3 COL24A1 ENSG00000171502 "Collagen type XXIV alpha 1 chain" Q17RW2 1 85729233-86156943 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.0" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 59.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 6.2" "Lineage enriched" "Detected in single" 10 "dendritic cells: 6.2" "Cell line enhanced" "Detected in some" "ASC diff: 3.4;HSkMC: 3.2;Karpas-707: 6.0;NTERA-2: 3.1;RH-30: 4.4;SuSa: 4.6;U-266/70: 11.2" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" NA NA 12000 "unprognostic (3.00e-1)" "unprognostic (6.19e-2)" "unprognostic (2.21e-2)" "unprognostic (6.76e-3)" "unprognostic (1.82e-3)" "unprognostic (2.45e-2)" "unprognostic (2.44e-5)" "unprognostic (1.37e-1)" "unprognostic (4.08e-2)" "unprognostic (6.59e-2)" "unprognostic (3.89e-2)" "unprognostic (1.46e-1)" "unprognostic (3.48e-6)" "unprognostic (2.79e-5)" "unprognostic (5.07e-1)" "unprognostic (1.19e-1)" "unprognostic (9.90e-2)" 1.1 0.4 6.2 3.4 7.1 2.3 1.1 1.7 18.0 7.0 9.5 0.3 0.0 4.1 3.6 2.4 2.2 0.6 4.4 4.1 12.1 1.2 1.5 0.3 1.7 1.0 1.1 5.2 6.9 0.3 0.2 2.0 0.3 1.7 2.3 2.4 2.4 1.2 4.3 1.4 1.6 3.7 2.8 1.0 0.8 3.4 1.9 2.9 0.0 0.8 2.6 0.8 8.3 4.9 0.0 6.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.5 0.0 3.4 0.6 0.0 0.6 0.1 0.2 0.5 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.9 0.0 1.4 0.0 0.8 0.0 1.0 0.1 0.1 0.0 0.0 3.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 6.0 0.9 0.0 0.0 0.2 3.1 0.0 0.0 0.0 4.4 0.5 0.6 1.1 0.1 0.0 0.0 0.2 0.5 4.6 0.0 0.9 0.0 2.0 0.2 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 6.2 0.0 0.0 6.2 7.1 1.7 18.0 12.1 1.2 1.1 5.2 1.7 2.9 0.0 1.1 1.9 0.0 0.3 2.2 1.6 0.0 2.7 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.9 0.3 10.1 0.0 0.0 59.8 0.0 0.0 0.7 0.0 1.1 0.0 0.0 1.1 0.4 0.1 0.0 0.0 0.0 0.0 COL26A1 "EMI6, EMID2, Emu2" ENSG00000160963 "Collagen type XXVI alpha 1 chain" Q96A83 7 101362820-101559024 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 11.4;brain: 18.3" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 5.2;Hepatocytes: 2.6;Late spermatids: 2.2;Spermatogonia: 2.2" "Group enriched" "Detected in many" 6 "endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7" "Cell type enriched" "Detected in single" 63 "plasmacytoid DC: 11.4" "Lineage enriched" "Detected in single" 63 "dendritic cells: 11.4" "Cell line enhanced" "Detected in some" "AF22: 20.3;BEWO: 16.3;HAP1: 7.2;NTERA-2: 17.1;SuSa: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027059 Approved Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA027059: AB_1848142" "unprognostic (5.94e-3)" "unprognostic (2.16e-2)" "unprognostic (2.19e-2)" "unprognostic (4.67e-2)" "unprognostic (1.66e-1)" "unprognostic (3.35e-1)" "prognostic favorable (2.32e-5)" "unprognostic (1.48e-1)" "unprognostic (1.16e-1)" "unprognostic (2.85e-2)" "unprognostic (1.26e-3)" "unprognostic (1.78e-1)" "unprognostic (4.24e-3)" "unprognostic (3.60e-1)" "unprognostic (1.50e-1)" "unprognostic (7.48e-4)" "unprognostic (2.83e-3)" 0.0 4.1 2.5 0.3 7.0 0.3 0.2 0.4 18.3 0.1 0.0 0.2 0.0 0.1 0.5 0.3 0.0 0.2 0.3 0.1 3.3 3.1 4.8 0.6 0.9 0.0 8.1 0.2 3.1 6.7 0.0 0.5 0.6 3.7 0.0 0.0 0.2 1.1 0.0 0.1 0.1 0.1 0.3 0.4 0.2 0.8 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.5 20.3 1.2 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 3.2 0.0 0.0 0.0 7.2 0.0 0.0 0.7 0.8 0.0 0.0 5.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 17.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.1 13.7 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.1 1.1 0.0 0.0 0.0 0.5 0.2 0.0 0.5 0.0 2.6 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.3 0.0 0.0 0.5 COL27A1 "FLJ11895, KIAA1870, MGC11337" ENSG00000196739 "Collagen type XXVII alpha 1 chain" Q8IZC6 9 114155560-114312511 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.9;cervix, uterine: 41.9" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 73.9;Extravillous trophoblasts: 60.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 56.9" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 30.2;Hep G2: 25.5" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 23 "cerebellum: 141.7" "HPA021884, HPA048471" Uncertain "Secreted to extracellular matrix" NA NA "HPA021884: AB_2670857, HPA048471: AB_2680407" "unprognostic (4.45e-2)" "unprognostic (3.27e-1)" "unprognostic (1.32e-1)" "unprognostic (5.00e-2)" "prognostic unfavorable (7.11e-4)" "unprognostic (4.13e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (6.25e-2)" "unprognostic (1.71e-1)" "unprognostic (1.09e-3)" "unprognostic (3.31e-1)" "unprognostic (3.41e-2)" "unprognostic (2.97e-2)" "unprognostic (9.48e-2)" "unprognostic (6.21e-3)" "unprognostic (3.50e-3)" 4.7 4.2 6.0 4.2 4.6 0.1 4.1 56.9 5.7 41.9 4.4 2.6 5.7 2.9 25.9 17.0 3.6 6.4 6.3 3.3 4.9 1.7 11.0 16.5 4.4 2.9 5.8 1.8 13.1 12.9 0.7 2.2 9.0 8.6 9.8 1.0 9.6 4.1 11.3 4.0 11.9 3.5 8.4 7.3 3.0 9.7 2.7 5.1 2.8 6.1 5.2 3.2 5.7 17.9 0.9 0.4 2.0 0.2 0.5 0.3 0.1 2.0 4.1 9.8 3.5 0.7 1.1 30.2 4.7 3.2 3.4 2.9 4.3 0.1 0.0 1.2 2.3 2.6 4.9 3.3 4.4 1.9 0.0 0.4 0.0 3.4 25.5 1.0 0.0 10.9 2.7 1.2 4.2 1.9 1.9 5.1 4.0 0.0 1.0 1.9 0.9 0.0 1.8 3.5 8.0 1.1 13.6 9.9 1.9 8.1 2.2 0.1 0.1 0.2 0.1 0.5 3.9 0.9 3.1 4.7 3.0 6.1 0.4 7.3 0.5 0.0 0.0 2.5 0.0 4.6 0.6 0.2 0.4 0.2 0.2 0.2 0.3 0.3 0.2 0.1 0.9 0.3 0.2 2.0 0.5 0.1 0.4 0.2 0.1 6.0 4.6 56.9 5.7 4.9 1.7 5.8 1.8 8.6 5.1 3.0 16.5 1.5 4.6 24.2 0.6 24.9 73.9 0.0 6.8 8.7 5.9 0.7 3.3 9.2 1.1 3.6 0.0 0.0 4.3 60.6 14.4 5.3 0.0 35.8 5.2 1.6 4.6 6.2 1.0 0.9 17.8 0.6 21.9 0.0 1.6 6.1 5.4 0.8 4.2 5.7 1.0 25.8 35.4 0.2 1.9 19.6 1.9 0.0 2.2 1.6 COL2A1 "AOM, SEDC, STL1" ENSG00000139219 "Collagen type II alpha 1 chain" P02458 12 47972965-48004554 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 22.7;pituitary gland: 11.0;retina: 8.1;stomach 1: 11.3" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 12.7;Intestinal endocrine cells: 42.2;Muller glia cells: 19.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 55.2;HAP1: 34.6;HEK 293: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002214, HPA055753" Approved Approved Nucleoplasm "Secreted to extracellular matrix" No NA Nucleoplasm "CAB002214: AB_563666, HPA055753: AB_2682908" "unprognostic (7.25e-2)" "unprognostic (1.20e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-1)" "unprognostic (2.88e-2)" "unprognostic (3.08e-2)" "unprognostic (8.63e-2)" "unprognostic (2.77e-1)" "unprognostic (1.22e-1)" "unprognostic (3.12e-2)" "unprognostic (1.31e-4)" "unprognostic (2.64e-1)" "unprognostic (3.44e-3)" "unprognostic (1.89e-1)" "unprognostic (2.93e-1)" "unprognostic (2.07e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.1 2.2 0.3 0.0 0.7 0.9 0.9 0.0 0.2 0.3 0.0 0.0 0.3 22.7 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 1.4 0.0 0.0 0.7 1.3 0.0 0.0 11.0 0.4 1.9 2.6 0.4 8.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 11.3 2.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 34.6 0.0 0.0 0.0 12.8 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.9 0.9 0.5 1.3 0.0 0.7 1.9 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.2 0.0 42.2 0.0 0.0 7.1 0.9 0.0 0.0 0.0 0.3 19.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.5 0.7 0.0 0.7 0.0 0.9 0.1 COL3A1 EDS4A ENSG00000168542 "Collagen type III alpha 1 chain" P02461 2 188974320-189012746 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aortic aneurysm, Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 304.2;endometrium 1: 208.0" "Cell type enriched" "Detected in many" 4 "Fibroblasts: 1855.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 81.7;ASC diff: 151.5;ASC TERT1: 263.7;fHDF/TERT166: 106.1;HHSteC: 104.2;HSkMC: 196.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA007583, CAB016766, CAB059993" Approved Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 16000000 "Endoplasmic reticulum" "CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548" "unprognostic (1.12e-1)" "unprognostic (2.03e-2)" "unprognostic (1.02e-1)" "unprognostic (6.01e-2)" "unprognostic (2.78e-1)" "unprognostic (2.04e-1)" "unprognostic (6.94e-2)" "unprognostic (6.77e-3)" "unprognostic (3.57e-3)" "unprognostic (2.60e-2)" "unprognostic (1.89e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (3.59e-10)" "unprognostic (1.70e-3)" "unprognostic (3.76e-2)" "unprognostic (7.61e-2)" "unprognostic (6.17e-3)" 41.7 9.7 0.7 34.1 3.4 0.0 29.7 0.8 1.2 304.2 41.3 1.3 23.8 3.9 208.0 82.0 31.3 32.3 116.3 41.0 1.0 0.3 14.4 12.1 32.9 39.3 1.3 1.1 54.9 14.4 1.7 2.3 161.2 3.2 27.4 18.3 32.0 15.1 22.4 14.5 28.3 24.2 114.1 1.7 29.5 25.3 45.5 0.7 9.5 12.8 44.8 15.4 64.8 51.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.7 3.1 151.5 263.7 0.0 32.9 29.3 14.4 12.9 0.4 0.0 0.0 0.0 106.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 13.9 0.0 104.2 0.1 0.0 196.1 0.0 17.5 2.8 0.0 0.7 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.4 0.0 1.2 0.8 0.0 0.0 60.2 0.0 0.0 0.0 0.1 1.7 7.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.4 0.8 1.2 1.0 0.3 1.3 1.1 3.2 0.7 3.0 20.2 0.0 0.4 152.4 0.0 9.8 0.0 2.7 2.3 0.0 0.0 40.3 0.0 2.5 21.6 52.5 0.0 0.0 0.0 34.9 1855.8 0.5 5.8 0.9 81.7 0.0 5.8 358.5 0.8 11.8 299.1 3.8 163.6 0.0 0.0 0.0 6.1 0.0 221.7 0.0 0.0 446.3 215.4 1.1 1.0 136.1 105.6 0.0 0.0 0.3 COL4A4 CA44 ENSG00000081052 "Collagen type IV alpha 4 chain" P53420 2 227002711-227164453 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Alport syndrome, Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 28.7" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 68.5;Collecting duct cells: 43.6;Cone photoreceptor cells: 53.0;Muller glia cells: 117.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "memory B-cell: 8.0" "Lineage enriched" "Detected in many" 7 "B-cells: 8.0" "Cell line enhanced" "Detected in some" "HeLa: 23.1;hTERT-RPE1: 19.7;Karpas-707: 6.3;RPTEC TERT1: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (7.31e-2)" "unprognostic (7.56e-2)" "unprognostic (6.65e-2)" "unprognostic (4.88e-5)" "unprognostic (1.12e-1)" "unprognostic (2.92e-2)" "unprognostic (8.50e-3)" "unprognostic (5.14e-2)" "unprognostic (1.44e-1)" "unprognostic (1.69e-2)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "prognostic favorable (2.30e-13)" "unprognostic (1.53e-2)" "unprognostic (2.65e-1)" "unprognostic (1.30e-1)" "unprognostic (4.15e-2)" 1.6 8.8 1.2 7.2 2.4 0.2 1.3 1.0 1.8 1.0 1.1 0.7 16.1 1.2 4.8 12.7 2.4 3.0 13.7 11.5 1.4 1.5 28.7 1.9 15.8 13.0 2.4 0.0 3.2 6.6 0.5 15.3 0.7 7.4 7.2 1.2 8.3 1.4 10.9 7.5 0.9 3.3 12.0 4.6 3.7 1.9 1.9 1.5 0.9 12.1 6.6 6.2 3.9 3.7 8.0 0.0 0.1 0.0 1.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.4 0.0 0.5 0.0 1.2 0.0 0.5 0.0 2.2 0.7 0.2 0.0 2.4 0.0 23.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 19.7 0.0 0.7 0.0 6.3 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.9 10.6 3.9 0.6 0.0 1.4 0.1 0.0 0.1 0.3 0.0 0.0 0.0 1.9 0.0 0.2 4.8 3.5 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.5 0.0 0.0 8.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.2 2.4 1.0 1.8 1.4 1.5 2.4 0.0 7.4 1.5 68.5 17.9 2.2 0.4 0.5 29.8 2.6 15.3 0.0 11.4 43.6 53.0 0.0 1.7 0.2 0.7 0.3 0.0 0.0 3.2 0.0 0.7 0.1 0.0 0.5 0.1 0.0 1.2 2.5 0.3 2.1 23.3 0.7 0.0 0.0 0.0 117.3 3.3 0.0 25.5 2.2 7.4 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 COL4A5 "ASLN, ATS" ENSG00000188153 "Collagen type IV alpha 5 chain" P29400 X 108439844-108697545 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Alport syndrome, Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 25.8;Basal keratinocytes: 23.9;Peritubular cells: 34.6;Urothelial cells: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 28.5;HHSteC: 32.8;HUVEC TERT2: 30.8;TIME: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077177 Approved "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" Vesicles "HPA077177: " "unprognostic (2.58e-2)" "unprognostic (2.57e-2)" "unprognostic (3.64e-2)" "unprognostic (3.98e-2)" "unprognostic (1.11e-1)" "unprognostic (1.61e-1)" "unprognostic (1.97e-2)" "unprognostic (7.27e-2)" "unprognostic (2.70e-1)" "unprognostic (2.20e-1)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.41e-5)" "unprognostic (2.10e-3)" "unprognostic (1.70e-1)" "unprognostic (2.61e-2)" "unprognostic (1.06e-1)" 3.3 2.7 13.1 1.7 27.7 0.3 5.8 1.8 16.1 16.9 3.7 47.2 9.5 2.7 31.4 18.2 6.9 19.3 12.6 5.9 13.9 6.2 5.9 1.7 5.9 0.9 46.6 15.7 11.5 2.8 22.3 10.2 9.7 19.5 18.0 4.1 5.8 3.7 23.9 4.8 17.5 3.1 32.8 20.5 2.8 17.7 2.8 40.5 0.0 5.4 0.9 0.9 23.9 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 8.8 15.8 5.0 6.2 3.6 0.1 0.9 3.9 4.8 7.9 7.9 0.6 1.3 0.0 0.6 2.9 7.1 4.4 14.9 6.1 2.1 3.8 1.1 28.5 0.9 32.8 0.0 4.5 17.0 18.1 5.9 12.7 15.4 30.8 0.0 0.0 0.0 4.6 0.6 0.0 0.1 4.7 0.0 5.3 0.0 0.0 0.0 12.0 8.8 0.0 0.0 23.0 0.7 1.9 23.3 4.3 0.0 29.1 3.2 1.0 2.1 1.3 0.6 0.0 0.0 2.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 27.7 1.8 16.1 13.9 6.2 46.6 15.7 19.5 40.5 6.0 5.3 0.0 25.8 23.9 0.3 8.9 0.0 4.0 11.4 19.2 0.0 0.6 0.0 0.2 0.1 2.9 0.0 0.0 0.8 0.3 8.5 8.2 1.1 0.4 0.4 0.0 0.0 4.9 0.3 1.2 18.7 0.8 1.7 0.0 0.0 13.0 0.5 0.0 34.6 0.0 0.4 6.5 18.6 0.3 0.7 13.9 0.6 0.0 0.0 22.6 COL5A2 ENSG00000204262 "Collagen type V alpha 2 chain" P05997 2 189031896-189179879 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Fibroblasts: 166.6;Ito cells: 41.1;Leydig cells: 45.1;Sertoli cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 68.1;BJ hTERT+ SV40 Large T+ RasG12V: 58.6;fHDF/TERT166: 63.4;HSkMC: 52.3;SuSa: 59.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA 230000 "unprognostic (7.45e-2)" "unprognostic (6.44e-3)" "unprognostic (1.22e-1)" "unprognostic (9.31e-2)" "unprognostic (2.01e-1)" "unprognostic (1.13e-1)" "unprognostic (6.28e-2)" "prognostic unfavorable (5.37e-4)" "unprognostic (5.97e-2)" "unprognostic (1.78e-2)" "unprognostic (4.44e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (1.53e-10)" "unprognostic (4.57e-3)" "unprognostic (3.76e-2)" "unprognostic (8.30e-2)" "prognostic unfavorable (3.58e-4)" 31.8 2.9 1.8 14.9 4.7 0.0 18.1 0.6 8.8 51.7 25.9 0.9 5.0 3.5 42.6 19.1 11.5 13.2 30.6 11.3 5.6 1.7 3.5 4.2 15.1 9.2 1.1 4.3 13.6 3.9 2.5 4.6 40.3 1.9 13.5 9.4 4.4 4.9 5.3 3.7 7.8 12.9 35.1 2.3 8.8 13.6 10.1 0.4 1.3 6.2 18.7 5.8 19.7 18.8 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.0 11.0 21.5 9.7 32.7 44.3 0.0 31.7 36.1 68.1 58.6 9.0 0.0 0.0 0.3 63.4 3.4 0.2 0.4 0.2 23.3 0.0 0.1 0.1 0.1 0.0 44.1 0.0 0.0 52.3 0.8 19.4 6.8 13.9 16.1 0.0 0.0 0.0 15.9 0.2 0.0 0.0 3.1 0.0 10.7 0.0 4.7 0.0 0.0 2.7 0.1 0.1 0.4 0.3 0.7 59.2 0.2 0.0 13.4 32.5 3.5 7.6 6.4 0.0 0.0 0.0 4.8 0.0 34.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 4.7 0.6 8.8 5.6 1.7 1.1 4.3 1.9 0.4 0.0 1.0 0.0 0.1 23.2 1.7 1.6 0.0 1.4 0.0 1.8 0.0 3.6 1.7 0.7 0.5 5.8 0.0 0.0 0.6 2.9 166.6 0.4 0.0 5.5 6.0 0.0 37.1 41.1 0.8 0.5 45.1 0.7 20.3 1.0 0.2 0.6 1.6 0.0 18.4 1.0 0.5 45.3 33.5 2.6 1.6 16.4 5.1 0.0 0.0 0.4 COL5A3 ENSG00000080573 "Collagen type V alpha 3 chain" P25940 19 9959561-10010471 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 48.9" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 63.5;Sertoli cells: 90.5;Smooth muscle cells: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 23.9;BJ: 13.8;BJ hTERT+: 15.5;BJ hTERT+ SV40 Large T+: 8.6;HSkMC: 17.2;WM-115: 15.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA048256 Approved "Secreted to extracellular matrix" NA NA 210000 "HPA048256: AB_2680330" "unprognostic (1.17e-1)" "unprognostic (1.35e-2)" "unprognostic (4.63e-2)" "unprognostic (3.24e-2)" "unprognostic (6.84e-3)" "unprognostic (3.01e-1)" "unprognostic (7.47e-2)" "unprognostic (1.79e-2)" "unprognostic (2.36e-1)" "unprognostic (2.27e-1)" "unprognostic (4.62e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (7.17e-8)" "unprognostic (3.25e-2)" "unprognostic (7.31e-3)" "unprognostic (6.00e-2)" "prognostic unfavorable (6.87e-5)" 48.9 2.6 11.6 10.8 15.9 0.4 27.0 3.2 11.9 24.5 7.8 3.2 3.1 3.6 17.5 9.8 11.3 8.1 10.7 9.5 10.1 3.0 1.9 4.1 6.4 9.2 5.2 3.5 3.4 3.8 3.2 0.9 30.2 4.5 6.8 2.2 9.7 5.1 9.1 15.4 19.0 3.9 9.6 2.5 1.3 3.4 5.3 2.6 1.6 4.5 11.5 4.7 7.3 10.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 7.6 23.9 0.0 13.8 15.5 8.6 3.4 0.0 0.0 0.0 0.1 2.5 0.2 1.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 17.2 0.3 3.1 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.8 0.1 0.0 0.0 0.0 7.0 3.2 0.3 0.0 0.0 0.0 0.0 0.9 0.0 15.4 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.6 15.9 3.2 11.9 10.1 3.0 5.2 3.5 4.5 2.6 0.0 0.0 0.0 0.1 3.8 63.5 3.1 0.0 1.4 0.0 0.0 5.9 0.1 0.0 0.1 5.8 3.8 0.0 0.0 0.0 0.2 13.8 0.3 0.0 17.3 0.5 3.2 0.0 6.7 0.0 0.9 16.1 0.0 13.5 0.0 0.0 1.6 0.3 0.0 7.8 0.0 22.9 90.5 30.6 0.2 0.1 6.1 0.1 0.0 0.0 0.3 COL9A1 ENSG00000112280 "Collagen type IX alpha 1 chain" P20849 6 70215061-70303083 "Disease related genes, Predicted secreted proteins" "Deafness, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 29.6;retina: 52.6" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 18.1;Horizontal cells: 33.4;Muller glia cells: 88.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 23.7;NTERA-2: 8.0" "Not detected" "Not detected" HPA074749 Enhanced "Secreted to extracellular matrix" NA NA "HPA074749: AB_2732266" "unprognostic (2.18e-2)" "unprognostic (2.16e-1)" "unprognostic (2.25e-2)" "unprognostic (3.48e-3)" "unprognostic (5.72e-2)" "unprognostic (5.32e-4)" "unprognostic (3.24e-3)" "unprognostic (8.79e-2)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (8.27e-2)" "unprognostic (2.52e-1)" "unprognostic (5.69e-2)" "unprognostic (1.54e-1)" "unprognostic (2.09e-1)" "unprognostic (2.78e-1)" "unprognostic (3.62e-2)" 0.7 0.6 8.5 0.7 7.5 0.5 0.6 3.6 4.7 0.6 1.1 7.2 0.0 1.8 1.1 0.8 0.8 0.7 1.1 5.6 8.4 9.4 1.1 0.5 0.6 0.6 10.3 1.7 0.6 0.5 0.9 3.3 0.6 5.6 29.6 1.4 52.6 3.0 1.1 0.6 0.6 2.0 0.9 5.3 0.6 2.6 4.1 6.9 0.0 1.0 0.2 0.7 0.7 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 7.5 3.6 4.7 8.4 9.4 10.3 1.7 5.6 6.9 0.0 0.0 0.0 0.1 0.0 0.2 3.5 0.0 0.0 0.0 0.0 3.9 0.0 1.7 0.0 18.1 0.0 0.2 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.1 33.4 1.2 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.4 88.9 0.0 0.0 0.4 0.0 1.8 0.0 1.4 0.6 0.7 0.0 0.0 0.0 1.1 0.1 COL9A2 "EDM2, MED" ENSG00000049089 "Collagen type IX alpha 2 chain" Q14055 1 40300487-40317813 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Deafness, Disease mutation, Dwarfism, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.3;pituitary gland: 32.1;retina: 40.8" "Cell type enriched" "Detected in many" 9 "Muller glia cells: 280.3" "Cancer enhanced" "Detected in all" "prostate cancer: 68.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 6.4;myeloid DC: 2.7" "Group enriched" "Detected in many" 6 "dendritic cells: 2.7;granulocytes: 6.4" "Cell line enhanced" "Detected in some" "HDLM-2: 35.4;HMC-1: 34.1;THP-1: 38.3" "Low region specificity" "Detected in all" "HPA056316, HPA075286" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA Vesicles Nucleoplasm "HPA056316: AB_2683099, HPA075286: AB_2732288" "unprognostic (1.42e-2)" "unprognostic (3.54e-2)" "unprognostic (8.94e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (4.46e-2)" "unprognostic (1.83e-3)" "unprognostic (2.06e-2)" "unprognostic (9.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.56e-3)" "unprognostic (2.26e-1)" "unprognostic (1.16e-3)" "unprognostic (4.28e-2)" "unprognostic (2.56e-1)" "unprognostic (5.89e-2)" "unprognostic (1.71e-2)" 0.7 2.3 17.2 2.6 19.5 7.6 3.1 2.3 12.1 10.0 3.6 32.0 17.4 4.6 3.9 1.5 0.7 3.7 6.5 1.0 20.8 14.5 4.3 0.6 2.8 4.2 29.8 10.5 0.6 1.7 28.3 32.1 0.9 16.3 8.8 2.6 40.8 13.7 21.3 0.3 2.0 3.3 1.3 35.3 3.2 12.8 0.8 19.7 0.2 4.3 0.9 2.5 4.0 0.5 0.7 2.7 6.4 0.7 0.4 0.3 0.1 4.3 0.1 0.7 0.3 1.0 0.5 2.9 0.0 0.0 0.2 0.5 0.1 2.5 1.2 3.8 0.1 0.0 0.7 0.0 0.0 0.1 35.4 0.5 0.7 0.3 9.9 0.6 0.3 34.1 1.8 0.0 0.0 0.0 0.2 0.0 0.5 0.0 7.4 0.0 0.9 0.4 0.7 0.8 0.0 0.4 0.8 0.0 2.4 0.0 5.2 0.5 0.8 0.0 4.4 0.4 2.6 5.6 38.3 0.0 0.0 4.5 0.0 0.1 0.5 0.0 1.2 0.3 4.5 0.2 0.0 0.2 6.4 0.0 0.5 0.0 0.5 0.2 0.0 2.7 0.7 0.1 0.0 1.1 0.4 0.7 0.3 0.3 0.1 17.2 19.5 2.3 10.8 20.8 14.5 29.8 10.5 16.3 19.7 0.0 3.5 4.5 2.6 0.9 1.8 0.8 7.6 1.4 3.4 24.4 0.0 2.3 0.0 6.3 0.0 0.0 3.3 0.0 0.7 0.4 1.4 7.8 26.4 0.0 3.3 0.0 12.2 1.3 0.3 0.8 2.0 6.5 1.7 30.7 5.5 280.3 3.6 7.0 0.0 0.1 7.8 0.0 0.9 2.6 2.6 0.5 1.1 2.2 12.2 11.1 COL9A3 "DJ885L7.4.1, EDM3, FLJ90759, IDD, MED" ENSG00000092758 "Collagen type IX alpha 3 chain" Q14050 20 62816244-62841159 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.4;retina: 37.2;salivary gland: 38.9;thyroid gland: 18.1" "Group enriched" "Detected in many" 5 "Early spermatids: 120.8;Late spermatids: 311.3;Muller glia cells: 91.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 53.7;Hep G2: 21.2;SK-MEL-30: 17.6;WM-115: 21.3" "Low region specificity" "Detected in all" "HPA040125, HPA058323" Supported Approved "Nucleoplasm,Intermediate filaments" "Secreted to extracellular matrix" NA NA Nucleoplasm "Intermediate filaments" "HPA040125: AB_10805604, HPA058323: AB_2683679" "unprognostic (1.14e-3)" "unprognostic (2.14e-2)" "unprognostic (3.93e-1)" "unprognostic (1.21e-3)" "unprognostic (4.25e-2)" "unprognostic (2.39e-2)" "unprognostic (2.33e-1)" "unprognostic (1.24e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-1)" "unprognostic (2.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.67e-1)" 2.2 2.0 11.2 2.3 16.3 1.2 1.5 1.5 8.9 1.7 3.4 26.4 1.6 2.3 1.8 1.5 1.6 1.2 1.4 2.1 14.9 9.8 1.4 1.3 1.3 1.4 18.4 8.1 1.6 5.4 1.1 5.3 1.9 12.4 1.7 1.3 37.2 38.9 3.4 1.5 1.8 2.5 1.4 25.0 1.2 1.8 6.4 15.2 0.0 18.1 1.4 1.2 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.3 53.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.5 21.2 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.2 2.4 2.9 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 17.6 1.8 0.1 1.9 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 16.3 1.5 8.0 14.9 9.8 18.4 8.1 12.4 15.2 3.0 0.0 13.7 1.7 2.9 1.0 1.2 0.0 0.0 0.0 5.2 9.8 4.0 1.7 1.3 120.8 3.1 0.9 0.0 0.0 35.4 10.4 0.9 0.0 2.4 2.1 0.0 4.1 3.1 2.7 311.3 3.7 1.3 3.3 0.0 2.6 91.3 0.1 6.2 1.4 9.5 2.5 0.0 1.1 2.5 4.1 6.0 3.3 0.0 1.5 0.8 CRTAC1 "ASPIC1, CEP-68, FLJ10320" ENSG00000095713 "Cartilage acidic protein 1" Q9NQ79 10 97865000-98030828 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 34.0;lung: 42.1;retina: 31.6;seminal vesicle: 31.1" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 90.9;Club cells: 66.0" "Cancer enhanced" "Detected in many" "melanoma: 43.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 3.6;HMC-1: 3.3;HUVEC TERT2: 8.9;SCLC-21H: 5.9;SK-MEL-30: 9.8;TIME: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA008175 Enhanced "Secreted to extracellular matrix" NA NA 360000000 "HPA008175: AB_1847254" "unprognostic (2.55e-1)" "unprognostic (6.41e-3)" "unprognostic (4.90e-3)" "prognostic unfavorable (5.01e-6)" "unprognostic (2.54e-1)" "unprognostic (6.96e-3)" "unprognostic (9.30e-2)" "unprognostic (9.13e-2)" "unprognostic (1.02e-2)" "unprognostic (3.01e-1)" "unprognostic (7.66e-2)" "unprognostic (1.69e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.70e-4)" "unprognostic (1.05e-2)" "unprognostic (3.29e-3)" "prognostic favorable (1.51e-4)" 4.5 1.4 6.2 1.6 7.2 0.8 2.0 7.2 27.3 3.9 6.0 3.8 4.5 1.2 1.2 4.8 7.9 34.0 1.1 6.2 5.5 7.0 3.1 1.1 42.1 1.1 9.2 5.8 2.2 1.8 1.4 3.2 0.8 27.5 3.3 1.1 31.6 3.4 31.1 1.4 2.9 1.2 3.6 6.8 0.8 1.0 4.0 2.7 0.0 4.4 0.7 1.0 25.5 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.0 0.3 0.8 0.0 3.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 5.9 1.3 0.7 0.0 9.8 0.4 0.1 0.0 11.9 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 7.2 7.2 18.7 5.5 7.0 9.2 5.8 27.5 2.7 20.8 90.9 0.0 2.0 1.3 5.7 3.9 2.5 1.4 66.0 8.7 0.0 0.0 0.0 4.3 0.0 1.6 0.0 0.0 0.6 0.0 1.7 0.4 4.7 0.0 0.0 0.0 1.7 5.5 0.3 0.2 0.0 0.3 8.5 0.0 0.0 14.5 0.8 0.0 0.4 0.0 3.6 0.0 0.5 0.9 1.7 0.4 0.0 0.0 0.0 1.1 DCN "DSPG2, SLRR1B" ENSG00000011465 Decorin P07585 12 91140484-91183123 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Corneal dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Fibroblasts: 3854.4;Leydig cells: 5816.6;Peritubular cells: 1745.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "basophil: 18.7" "Lineage enriched" "Detected in single" 21 "granulocytes: 18.7" "Cell line enhanced" "Detected in some" "ASC diff: 232.6;ASC TERT1: 179.3;BJ hTERT+: 179.9;HSkMC: 163.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003315, CAB017118, HPA064736, CAB068930" Enhanced "Secreted to extracellular matrix" NA NA 1300000 "CAB017118: , CAB068930: AB_425394, HPA003315: AB_1078639, HPA064736: AB_2685340" "unprognostic (1.73e-1)" "unprognostic (1.90e-1)" "unprognostic (1.43e-1)" "unprognostic (3.22e-2)" "unprognostic (8.63e-2)" "unprognostic (1.34e-1)" "unprognostic (1.01e-2)" "unprognostic (2.68e-1)" "unprognostic (1.98e-1)" "unprognostic (6.12e-2)" "unprognostic (1.65e-1)" "unprognostic (5.15e-2)" "prognostic unfavorable (1.46e-5)" "unprognostic (3.06e-3)" "unprognostic (5.37e-2)" "unprognostic (1.59e-3)" "unprognostic (7.56e-3)" 152.8 64.6 4.8 52.8 8.3 0.0 137.1 4.5 5.8 177.7 60.6 5.1 105.8 7.8 124.0 266.8 142.9 113.6 94.3 190.2 5.2 4.0 35.4 35.1 107.0 27.5 16.7 9.1 265.5 25.7 1.5 12.7 192.0 12.4 130.7 28.3 40.7 32.7 51.8 77.2 76.0 34.9 222.4 24.9 1.8 47.5 116.5 6.0 3.3 74.2 99.4 29.3 187.8 113.8 0.8 0.6 18.7 0.3 0.5 0.4 0.0 0.0 0.0 0.3 0.0 232.6 179.3 0.3 41.2 179.9 1.9 2.1 0.0 0.0 0.0 0.0 35.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 1.3 0.0 49.7 0.0 0.0 163.1 0.4 5.2 2.5 0.8 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 9.3 0.0 33.1 0.0 0.1 0.1 0.1 0.5 0.1 0.0 18.7 0.3 0.6 0.4 0.2 0.3 0.4 0.3 0.3 0.1 0.8 0.4 0.4 2.7 0.5 0.2 0.6 0.3 0.0 4.8 8.3 4.5 5.8 5.2 4.0 16.7 9.1 12.4 6.0 38.7 48.6 0.0 2.9 541.1 1.7 148.1 0.0 10.7 21.6 19.2 0.0 35.4 1.7 0.9 19.7 45.0 0.0 0.0 0.0 24.9 3854.4 4.6 19.8 2.0 52.9 0.0 0.0 357.3 3.4 36.2 5816.6 40.7 575.3 0.0 0.0 2.3 4.2 0.0 1745.6 0.3 0.6 207.0 499.8 12.6 6.3 421.7 53.4 6.9 0.0 8.9 ECM2 ENSG00000106823 "Extracellular matrix protein 2" O94769 9 92493554-92536655 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Fibroblasts: 43.8;Hepatocytes: 36.8;Leydig cells: 113.1;Peritubular cells: 65.4;Smooth muscle cells: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "ASC diff: 11.4;ASC TERT1: 20.8;HSkMC: 21.9;hTCEpi: 24.9;hTERT-HME1: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035347 Approved "Secreted to extracellular matrix" NA NA 5500000 "HPA035347: AB_10669856" "unprognostic (2.48e-1)" "unprognostic (2.11e-1)" "unprognostic (2.27e-2)" "unprognostic (2.20e-2)" "unprognostic (5.35e-2)" "unprognostic (2.30e-1)" "prognostic favorable (4.50e-5)" "unprognostic (6.14e-2)" "unprognostic (2.14e-2)" "unprognostic (1.79e-1)" "unprognostic (1.66e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (4.09e-6)" "unprognostic (1.12e-3)" "unprognostic (2.39e-2)" "unprognostic (3.80e-2)" "unprognostic (6.63e-3)" 43.3 5.0 5.4 7.2 4.3 0.0 18.6 9.5 1.9 20.9 6.5 5.4 11.6 2.9 14.7 27.5 8.4 11.6 11.2 13.8 9.3 3.6 10.1 28.2 8.8 2.3 11.0 4.2 34.6 1.9 4.9 4.7 1.4 17.8 16.4 2.4 5.8 3.4 8.1 6.0 5.8 5.4 10.1 15.8 0.5 2.8 15.4 7.4 1.1 8.3 15.5 2.4 13.7 8.8 0.3 0.6 0.0 0.5 0.1 0.5 0.0 0.4 0.0 0.2 0.0 11.4 20.8 0.7 0.4 0.6 0.0 0.3 0.3 0.0 0.0 0.0 1.1 0.2 0.3 0.5 0.4 0.0 2.4 0.0 0.0 0.0 0.0 1.9 0.1 0.0 21.9 24.9 0.5 6.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.5 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.5 0.2 0.5 0.0 0.0 0.1 0.1 0.6 0.0 0.0 5.4 4.3 9.5 1.9 9.3 3.6 11.0 4.2 17.8 7.4 0.0 2.9 0.0 0.1 10.2 2.5 4.5 0.0 5.3 3.4 0.0 2.0 0.0 0.0 0.0 3.8 2.9 0.7 0.0 0.0 9.4 43.8 0.1 0.0 36.8 0.4 0.0 0.0 3.7 1.9 5.5 113.1 1.1 5.0 0.0 0.0 0.0 0.0 0.0 65.4 6.7 2.8 25.8 33.0 0.7 0.6 8.0 0.7 0.0 0.0 0.1 EFEMP2 "FBLN4, UPH1" ENSG00000172638 "EGF containing fibulin extracellular matrix protein 2" O95967 11 65866441-65873592 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Fibroblasts: 114.5;Leydig cells: 86.6;Peritubular cells: 100.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.5;gdT-cell: 4.4;NK-cell: 2.3" "Group enriched" "Detected in many" 7 "granulocytes: 1.5;NK-cells: 2.3;T-cells: 4.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.8;BJ: 27.4;BJ hTERT+: 34.2;fHDF/TERT166: 49.4;HSkMC: 33.2;hTERT-RPE1: 34.7;LHCN-M2: 29.8;U-138 MG: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023270 Approved "Secreted to extracellular matrix" NA NA 1100000 "HPA023270: AB_1848019" "unprognostic (3.13e-1)" "unprognostic (2.15e-3)" "unprognostic (3.23e-2)" "unprognostic (5.11e-2)" "unprognostic (8.57e-3)" "unprognostic (1.50e-1)" "unprognostic (1.67e-1)" "unprognostic (6.52e-2)" "unprognostic (1.13e-2)" "unprognostic (1.71e-1)" "unprognostic (4.89e-2)" "unprognostic (9.12e-2)" "prognostic unfavorable (3.94e-5)" "unprognostic (8.33e-3)" "unprognostic (6.35e-2)" "unprognostic (2.37e-1)" "unprognostic (2.58e-2)" 22.1 10.5 9.4 10.1 9.9 1.6 13.4 6.2 7.3 38.9 16.4 7.7 19.8 4.8 29.3 28.4 13.0 16.3 29.7 29.4 7.0 6.0 14.7 5.4 14.5 15.1 8.4 5.7 39.7 12.2 14.1 7.6 21.9 6.5 26.5 4.0 24.5 9.6 22.1 11.9 6.9 6.9 23.6 7.6 8.4 10.4 19.9 4.8 2.8 25.3 11.3 4.8 23.1 15.2 0.1 0.3 1.5 0.2 2.3 4.4 0.5 0.1 0.0 0.5 9.1 11.8 23.8 0.2 27.4 34.2 10.8 9.7 0.0 0.8 0.1 2.3 49.4 0.1 0.2 0.0 0.3 2.7 1.4 0.0 0.2 0.7 1.8 18.7 0.0 0.0 33.2 0.0 4.2 0.2 34.7 6.1 0.2 0.0 1.7 29.8 0.1 0.0 4.2 0.3 0.0 0.1 0.1 0.1 0.7 0.3 0.1 0.1 2.9 0.0 0.3 0.3 1.3 0.3 2.2 13.7 23.8 5.8 11.4 0.1 3.0 0.1 0.0 9.1 0.2 4.2 0.0 0.2 1.5 4.4 0.1 0.1 0.1 0.5 0.0 0.3 0.0 0.1 0.5 0.6 2.3 0.2 0.0 0.0 0.5 9.4 9.9 6.2 7.3 7.0 6.0 8.4 5.7 6.5 4.8 32.8 9.0 1.9 33.1 11.9 4.1 37.6 10.2 12.0 15.9 17.4 0.0 2.4 6.6 23.0 12.3 21.2 0.0 0.0 0.2 3.2 114.5 14.2 0.0 1.6 8.0 6.4 0.0 50.3 4.6 22.0 86.6 2.5 23.6 1.0 0.0 54.8 3.5 0.0 100.8 17.0 4.4 38.8 45.0 27.4 3.1 8.8 4.9 1.8 0.1 10.4 ELN "SVAS, WBS, WS" ENSG00000049540 Elastin P15502 7 74027789-74069907 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Fibroblasts: 53.4;Ito cells: 49.1;Leydig cells: 102.4;Peritubular cells: 139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 16.9;BJ: 23.4;fHDF/TERT166: 33.6;U-2197: 133.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "CAB010750, HPA018111, HPA056941" Supported Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 2900000 "Plasma membrane" "CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: AB_2683280" "unprognostic (1.51e-2)" "unprognostic (4.86e-2)" "unprognostic (2.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-2)" "unprognostic (2.72e-2)" "unprognostic (3.70e-3)" "unprognostic (1.23e-1)" "unprognostic (3.33e-2)" "unprognostic (2.00e-3)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (2.18e-3)" "unprognostic (1.79e-2)" "unprognostic (3.90e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.62e-3)" 35.0 8.8 4.3 14.9 3.6 0.0 24.8 27.8 5.8 23.3 12.1 12.9 9.1 3.2 22.3 26.0 30.1 17.1 30.8 41.5 5.4 3.0 8.3 3.7 49.7 7.5 4.4 9.2 10.6 35.3 0.7 6.1 22.5 13.7 25.1 4.6 34.3 16.8 14.5 6.0 23.6 9.2 34.7 9.9 10.7 16.0 8.1 6.4 0.9 11.9 10.3 4.4 34.0 21.7 0.4 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.3 0.1 0.0 16.9 0.1 0.1 23.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 33.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.3 0.1 0.1 0.0 9.0 0.1 0.0 0.0 4.6 11.0 0.0 0.2 0.0 1.7 0.1 0.0 0.0 0.0 0.0 133.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.3 3.6 27.8 5.8 5.4 3.0 4.4 9.2 13.7 6.4 0.0 8.3 0.0 13.2 9.7 0.9 8.9 2.5 4.0 5.7 7.0 2.0 0.1 0.0 0.2 2.5 26.4 0.0 0.0 3.5 0.2 53.4 1.2 0.0 2.1 0.4 6.4 1.7 49.1 0.3 4.2 102.4 1.0 13.5 0.0 1.3 17.8 1.5 0.0 139.3 0.0 0.7 0.0 31.5 0.9 1.1 9.5 0.1 0.0 0.0 0.8 EMILIN3 "C20orf130, dJ620E11.4, EMILIN5" ENSG00000183798 "Elastin microfibril interfacer 3" Q9NT22 20 41359966-41366827 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 49.9" "Cell type enhanced" "Detected in some" 25 "Leydig cells: 1.7;Peritubular cells: 4.6" "Cancer enhanced" "Detected in many" "glioma: 10.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.9;HAP1: 12.1;NTERA-2: 7.7;SCLC-21H: 14.4" "Region enriched" "Detected in single" 29 "cerebellum: 3.7" "Low region specificity" "Detected in single" "HPA044034, HPA059912, HPA078559" Enhanced Approved "Golgi apparatus,Microtubules,Cytokinetic bridge" "Secreted to extracellular matrix" NA NA 650000 "Golgi apparatus" "Microtubules, Cytokinetic bridge" "HPA044034: AB_2678783, HPA059912: AB_2684158, HPA078559: " "unprognostic (1.66e-4)" "unprognostic (1.85e-2)" "unprognostic (2.50e-2)" "unprognostic (2.14e-1)" "unprognostic (2.65e-1)" "unprognostic (2.15e-2)" "unprognostic (1.71e-1)" "unprognostic (7.66e-2)" "unprognostic (2.18e-3)" "unprognostic (2.57e-1)" "unprognostic (6.54e-2)" "unprognostic (7.66e-2)" "unprognostic (3.13e-7)" "unprognostic (2.64e-2)" "unprognostic (1.05e-1)" "unprognostic (1.97e-1)" "unprognostic (9.62e-2)" 0.9 1.9 2.9 1.6 2.0 0.5 3.5 0.7 8.2 7.1 4.1 1.9 8.5 1.1 2.7 49.9 1.1 3.2 0.9 6.0 3.0 2.9 0.8 0.6 0.7 0.6 3.8 0.7 9.2 0.6 0.5 1.6 0.6 2.7 8.1 0.8 5.8 1.5 10.0 1.3 3.4 1.4 1.6 2.2 0.6 1.9 4.3 2.3 0.3 0.7 2.9 0.8 2.4 5.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.4 0.0 12.1 0.0 0.3 0.0 1.4 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.4 1.4 0.0 0.0 0.0 2.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.9 2.0 0.7 8.2 3.0 2.9 3.8 0.7 2.7 2.3 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 EPYC "DSPG3, Pg-Lb, SLRR3B" ENSG00000083782 Epiphycan Q99645 12 90963679-91005026 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "placenta: 67.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "hTERT-RPE1: 8.2;U-266/70: 2.0" "Region enhanced" "Detected in single" "midbrain: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 3.8;basal ganglia: 3.8;cerebral cortex: 6.2;hippocampal formation: 4.4" "HPA038212, HPA045455" Approved "Secreted to extracellular matrix" NA NA "HPA038212: AB_10672739, HPA045455: AB_2679330" "unprognostic (2.25e-1)" "unprognostic (2.08e-1)" "unprognostic (2.79e-1)" "unprognostic (4.28e-2)" "unprognostic (1.81e-2)" "unprognostic (4.07e-2)" "unprognostic (9.20e-2)" "unprognostic (3.23e-1)" "prognostic unfavorable (1.85e-4)" "unprognostic (2.77e-2)" "unprognostic (6.44e-9)" "unprognostic (2.83e-2)" "unprognostic (3.08e-1)" "unprognostic (8.68e-2)" "unprognostic (1.20e-1)" 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.8 0.4 0.1 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 2.5 0.0 0.0 0.0 67.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FBLN2 ENSG00000163520 "Fibulin 2" P98095 3 13549131-13638422 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 80.5" "Group enriched" "Detected in many" 6 "Fibroblasts: 266.2;Leydig cells: 158.2;Peritubular cells: 213.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 9.2;naive CD8 T-cell: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 75.4;fHDF/TERT166: 49.5;HMC-1: 60.2;HSkMC: 43.7;U-2197: 26.7" "Region enriched" "Detected in some" 7 "olfactory region: 15.4" "Low region specificity" "Detected in all" "HPA001934, CAB018622" Enhanced Supported "Plasma membrane" "Secreted to extracellular matrix" NA NA 28000000 "Plasma membrane" "CAB018622: AB_2294196, HPA001934: AB_1078827" "unprognostic (1.19e-1)" "unprognostic (7.76e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (2.82e-2)" "unprognostic (1.05e-1)" "prognostic favorable (3.17e-4)" "unprognostic (8.02e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "unprognostic (2.57e-1)" "unprognostic (4.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.89e-2)" "unprognostic (2.82e-2)" "unprognostic (2.61e-2)" "unprognostic (1.41e-1)" 58.5 2.7 1.8 8.0 2.2 0.1 34.3 0.8 3.2 21.4 11.5 1.3 9.5 2.1 11.6 23.6 32.7 7.2 21.9 80.5 1.6 1.7 2.1 1.2 7.8 5.1 2.4 1.4 6.3 3.2 1.1 0.9 31.8 2.3 22.1 4.2 7.9 10.8 3.3 20.1 20.8 6.1 42.9 1.5 2.3 6.9 41.8 0.5 4.8 20.7 23.8 8.5 34.2 36.3 2.2 9.2 0.0 0.0 0.4 5.4 1.1 0.0 0.2 9.8 0.0 75.4 10.2 4.5 23.5 18.8 23.6 15.6 1.5 0.0 0.0 1.1 49.5 0.0 0.0 0.0 0.1 4.4 0.0 0.0 18.6 0.4 0.0 5.1 0.0 60.2 43.7 0.3 3.7 0.0 0.0 0.0 1.6 0.1 0.1 0.1 0.0 0.9 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.4 0.0 17.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 26.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 1.7 0.0 0.3 9.2 2.2 0.0 5.4 0.0 0.4 0.0 0.7 0.0 1.1 1.8 2.2 0.8 3.2 1.6 1.7 2.4 1.4 2.3 0.5 0.0 1.0 0.0 0.7 27.4 0.0 7.3 0.0 0.0 3.4 7.0 2.0 6.6 0.0 0.0 3.4 29.2 0.0 0.0 0.2 4.5 266.2 1.0 24.1 0.2 3.2 0.0 0.0 25.8 0.3 6.5 158.2 2.1 37.1 0.0 0.0 1.3 0.2 0.0 213.6 0.0 0.2 12.9 19.6 2.6 8.8 25.2 5.1 0.0 0.0 0.9 FBN2 "CCA, DA9" ENSG00000138829 "Fibrillin 2" P35556 5 128257909-128659185 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "placenta: 175.9" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 251.0;Syncytiotrophoblasts: 136.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;non-classical monocyte: 5.0" "Lineage enriched" "Detected in many" 5 "monocytes: 5.0" "Cell line enhanced" "Detected in many" "HHSteC: 38.0;HSkMC: 27.1;hTERT-HME1: 59.9;HUVEC TERT2: 33.7" "Region enhanced" "Detected in single" "olfactory region: 2.6" "Low region specificity" "Detected in some" "HPA012853, CAB026401" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 4600000 Cytosol Nucleoplasm "CAB026401: , HPA012853: AB_1848588" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (7.29e-3)" "unprognostic (1.79e-3)" "unprognostic (6.74e-2)" "unprognostic (2.33e-1)" "unprognostic (4.92e-3)" "unprognostic (9.41e-2)" "unprognostic (1.06e-2)" "unprognostic (4.66e-1)" "unprognostic (1.12e-1)" "unprognostic (8.69e-2)" "unprognostic (8.60e-5)" "unprognostic (1.04e-2)" "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (7.41e-5)" 0.3 7.9 0.3 1.0 0.3 1.6 0.1 0.2 0.3 1.5 0.7 0.4 1.0 0.2 2.9 0.6 1.1 0.6 0.2 6.7 0.2 0.5 0.2 0.2 0.2 1.3 0.2 0.4 0.9 0.1 0.0 1.3 175.9 0.4 1.0 0.8 6.2 0.4 0.9 0.2 0.3 0.5 0.8 0.4 0.6 0.5 4.6 0.2 0.3 0.9 0.4 0.7 0.4 1.2 0.0 1.1 0.6 5.0 0.0 0.0 0.4 0.0 4.5 16.4 0.0 2.7 4.7 3.4 17.9 0.0 15.9 11.9 0.0 0.0 0.0 0.0 23.9 0.0 2.7 10.6 2.7 14.9 0.0 4.2 0.0 7.5 0.0 38.0 2.3 0.0 27.1 1.4 6.7 59.9 5.1 33.7 0.0 0.0 0.0 9.8 0.0 0.0 0.9 7.1 0.0 5.4 5.1 5.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 14.0 0.0 5.0 0.0 6.4 12.2 18.3 0.0 0.0 0.0 0.0 1.9 0.0 6.7 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.0 5.0 0.0 0.0 0.4 0.3 0.3 0.2 0.3 0.2 0.5 0.2 0.4 0.4 0.2 0.0 0.3 0.0 0.1 0.0 0.0 11.3 0.0 0.0 2.3 0.0 0.0 251.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 27.7 3.3 1.5 0.0 0.0 29.6 0.0 0.0 0.0 12.9 5.3 1.1 1.8 1.7 0.0 0.0 3.1 0.1 0.0 2.1 0.0 0.0 6.5 0.2 12.7 3.8 0.4 136.7 0.0 0.0 0.1 FBN3 ENSG00000142449 "Fibrillin 3" Q75N90 19 8065402-8149846 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 5.2;salivary gland: 7.5" "Cell type enhanced" "Detected in some" 30 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 1.4;Cardiomyocytes: 2.0" "Cancer enhanced" "Detected in many" "testis cancer: 8.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.9;CACO-2: 3.7;NTERA-2: 12.6;REH: 18.2;SuSa: 4.9" "Low region specificity" "Detected in many" HPA049482 Uncertain "Secreted to extracellular matrix" NA NA "HPA049482: AB_2680786" "unprognostic (9.66e-3)" "unprognostic (5.15e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (5.15e-4)" "unprognostic (4.14e-2)" "unprognostic (5.14e-3)" "unprognostic (6.26e-2)" "unprognostic (4.10e-3)" "unprognostic (3.17e-2)" "unprognostic (8.94e-2)" "unprognostic (4.61e-2)" "unprognostic (1.53e-1)" "unprognostic (2.76e-2)" "unprognostic (1.34e-2)" "unprognostic (2.57e-1)" "unprognostic (1.17e-2)" "unprognostic (3.17e-1)" 0.2 0.0 1.0 0.2 1.2 0.0 0.5 0.2 2.4 0.2 0.2 2.8 0.2 0.0 0.7 0.2 0.5 1.8 0.2 0.2 1.0 1.1 3.6 0.5 5.2 0.2 2.4 0.2 0.8 0.2 0.0 1.9 0.2 2.1 1.7 0.3 0.2 7.5 0.2 0.9 0.6 0.3 0.3 2.0 0.2 0.1 1.1 1.7 0.8 3.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 3.7 0.4 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 12.6 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.2 2.4 1.0 1.1 2.4 0.2 2.1 1.7 6.0 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 FMOD SLRR2E ENSG00000122176 Fibromodulin Q06828 1 203340628-203351489 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Fibroblasts: 50.6;Leydig cells: 25.9;Mucus-secreting cells: 57.0;Peritubular cells: 26.9;Smooth muscle cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 6.2;CACO-2: 21.3;HHSteC: 6.9;HSkMC: 12.8;OE19: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA 2400000 "unprognostic (1.48e-1)" "unprognostic (8.88e-2)" "unprognostic (9.35e-2)" "unprognostic (2.70e-2)" "unprognostic (1.60e-2)" "unprognostic (4.17e-3)" "unprognostic (1.86e-1)" "unprognostic (3.30e-1)" "unprognostic (5.25e-3)" "unprognostic (1.06e-2)" "unprognostic (1.65e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.40e-5)" "unprognostic (9.40e-3)" "unprognostic (3.58e-2)" "unprognostic (1.27e-3)" "prognostic unfavorable (2.67e-4)" 35.9 6.0 1.0 12.6 2.0 0.0 32.2 1.2 2.0 62.5 14.2 2.0 12.0 12.1 69.6 43.6 16.9 31.2 87.1 58.3 1.1 1.2 10.8 6.1 22.8 27.4 3.0 2.5 86.7 39.4 5.0 12.1 21.0 5.0 37.5 16.0 44.3 25.0 16.2 20.1 10.5 8.4 27.4 7.5 18.3 36.5 14.2 0.6 2.7 57.6 20.4 37.6 32.0 42.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.4 0.1 4.0 4.5 0.0 0.6 21.3 0.0 0.0 0.5 4.3 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.5 0.0 6.9 0.0 0.0 12.8 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.5 0.1 1.1 0.0 0.2 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.0 1.2 2.0 1.1 1.2 3.0 2.5 5.0 0.6 0.0 7.5 0.0 5.1 6.2 0.0 0.8 0.0 1.4 3.4 7.0 0.0 0.7 0.0 1.2 0.0 5.4 0.8 0.0 0.6 0.6 50.6 13.8 0.0 0.0 1.1 0.0 5.8 13.5 0.0 0.0 25.9 0.6 11.8 1.0 57.0 7.8 2.1 0.0 26.9 0.0 0.8 6.5 33.2 0.0 0.0 3.8 2.6 0.0 6.8 1.0 FNDC1 "bA243O10.1, dJ322A24.1, FNDC2, KIAA1866" ENSG00000164694 "Fibronectin type III domain containing 1" Q4ZHG4 6 159169397-159272109 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 36.6" "Cell type enriched" "Detected in some" 5 "Fibroblasts: 15.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.5" "Region enriched" "Detected in single" 6 "hippocampal formation: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.4;fHDF/TERT166: 6.6;SuSa: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA030962, HPA030963" Approved Approved "Nuclear speckles" "Secreted to extracellular matrix" NA NA "Nuclear speckles" "HPA030962: AB_10696212, HPA030963: AB_2673676" "unprognostic (4.59e-2)" "unprognostic (9.17e-3)" "unprognostic (7.62e-2)" "prognostic favorable (6.10e-5)" "unprognostic (4.57e-1)" "unprognostic (2.11e-1)" "unprognostic (5.52e-2)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "unprognostic (1.08e-1)" "unprognostic (4.18e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.93e-6)" "unprognostic (6.49e-3)" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.76e-3)" 5.2 0.6 0.5 7.6 0.7 0.0 2.5 0.3 0.7 9.7 12.9 3.2 0.0 2.1 4.8 2.2 2.2 0.9 13.1 3.5 4.8 0.5 1.0 1.5 1.2 2.1 0.7 0.0 4.8 1.2 0.0 0.4 0.7 0.5 0.7 1.6 1.0 2.5 0.6 6.2 1.2 7.0 10.2 1.5 0.7 0.7 2.1 0.1 1.0 36.6 11.8 3.6 1.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.1 2.4 6.6 0.3 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.2 0.0 0.0 0.9 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 7.4 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.7 4.8 0.5 0.7 0.0 0.5 0.1 0.0 1.1 0.0 0.0 2.9 0.0 1.4 0.0 0.0 1.2 0.0 0.0 0.1 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 15.5 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.4 0.3 1.3 0.1 0.0 0.0 0.0 HAPLN1 CRTL1 ENSG00000145681 "Hyaluronan and proteoglycan link protein 1" P10915 5 83637805-83721613 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 41.8" "Cell type enhanced" "Detected in some" 20 "Cytotrophoblasts: 7.6;Extravillous trophoblasts: 9.6;Fibroblasts: 4.4;Hofbauer cells: 9.4;Syncytiotrophoblasts: 19.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "PC-3: 44.7;SuSa: 23.1;TIME: 28.3;U-2 OS: 46.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019105, HPA019482, HPA025238" Enhanced Approved Supported Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: " "unprognostic (5.74e-4)" "unprognostic (2.94e-2)" "unprognostic (6.58e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (2.76e-3)" "unprognostic (6.01e-4)" "unprognostic (2.52e-2)" "unprognostic (1.70e-1)" "unprognostic (9.04e-3)" "unprognostic (1.31e-1)" "unprognostic (2.28e-2)" "prognostic unfavorable (4.81e-9)" "unprognostic (6.87e-2)" "unprognostic (2.04e-1)" "unprognostic (8.62e-2)" "unprognostic (3.91e-2)" 0.1 0.0 5.4 1.5 3.9 0.0 0.1 0.6 4.7 0.1 4.7 0.1 0.1 3.8 0.5 0.1 1.2 0.0 0.5 1.8 3.4 1.3 0.4 0.1 0.9 0.1 1.7 0.7 0.2 0.2 0.0 0.1 41.8 1.5 4.9 5.8 1.5 0.9 0.1 0.1 0.5 9.3 0.3 0.6 0.1 2.4 0.1 0.1 0.1 0.3 0.5 0.3 0.9 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.1 0.0 0.0 28.3 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.4 3.9 0.6 4.4 3.4 1.3 1.7 0.7 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 4.4 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 HAPLN3 "EXLD1, HsT19883" ENSG00000140511 "Hyaluronan and proteoglycan link protein 3" Q96S86 15 88877288-88895626 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.4;lymphoid tissue: 23.6" "Cell type enriched" "Detected in many" 8 "Extravillous trophoblasts: 899.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 25.4" "Lineage enriched" "Detected in many" 5 "T-cells: 25.4" "Cell line enhanced" "Detected in many" "HDLM-2: 21.0;U-2 OS: 21.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039237 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA "Plasma membrane, Cytosol" "HPA039237: AB_10805357" "unprognostic (1.67e-2)" "unprognostic (1.04e-3)" "unprognostic (2.57e-1)" "unprognostic (2.53e-2)" "unprognostic (3.27e-1)" "unprognostic (2.24e-2)" "unprognostic (4.21e-1)" "unprognostic (3.82e-1)" "unprognostic (3.37e-3)" "unprognostic (7.37e-3)" "unprognostic (1.13e-3)" "unprognostic (4.30e-1)" "prognostic unfavorable (4.18e-13)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.12e-1)" 9.9 1.3 1.1 20.6 2.7 4.4 8.7 1.0 2.3 5.3 2.6 1.1 0.3 1.4 4.4 4.9 5.7 6.0 4.7 9.8 3.2 1.0 3.0 0.8 8.7 23.6 3.1 0.9 5.2 2.3 0.9 2.2 2.7 3.6 5.2 1.1 3.2 6.4 1.6 4.2 6.0 4.1 4.7 6.2 6.9 3.6 1.9 1.8 5.7 7.2 7.6 10.9 6.0 5.6 0.8 1.1 0.7 0.6 4.8 25.4 3.2 1.2 4.4 0.9 9.8 2.8 3.0 3.1 2.7 0.6 1.0 1.3 2.8 4.1 0.0 7.8 3.4 1.6 1.0 9.3 1.2 0.0 21.0 8.2 3.0 0.2 0.0 0.4 0.0 0.1 1.1 0.5 2.0 0.1 0.1 4.6 0.4 0.0 6.0 0.4 0.1 0.0 0.0 7.3 0.0 0.1 0.0 0.4 7.3 1.8 0.1 0.1 2.7 0.5 0.5 3.7 1.2 0.0 0.4 0.8 7.1 21.0 5.3 0.4 0.9 0.0 0.0 2.5 0.0 6.1 0.7 0.6 0.0 0.6 0.3 3.0 0.1 10.0 4.1 1.1 0.8 10.2 4.5 0.1 4.8 0.1 0.4 25.4 3.2 1.1 2.7 1.0 2.3 3.2 1.0 3.1 0.9 3.6 1.8 0.0 4.3 0.9 6.0 28.4 2.6 7.7 0.0 1.4 5.7 1.8 9.8 5.6 0.0 5.7 0.0 18.6 0.0 0.0 1.8 899.6 9.3 3.9 1.1 0.0 17.6 0.0 0.0 3.1 0.0 0.0 0.9 2.9 16.9 16.2 0.2 2.4 8.7 0.0 0.7 0.1 108.4 12.9 38.9 0.5 1.7 21.1 17.0 3.2 0.2 6.8 HPSE2 "HPA2, HPR2, UFS" ENSG00000172987 "Heparanase 2 (inactive)" Q8WWQ2 10 98457077-99235862 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 31.0;smooth muscle: 22.2" "Group enriched" "Detected in some" 6 "Early spermatids: 23.2;Late spermatids: 41.7" "Cancer enhanced" "Detected in some" "prostate cancer: 4.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.3;T-reg: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Group enriched" "Detected in some" 19 "BJ hTERT+: 12.3;HEL: 23.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA044603 Uncertain "Secreted to extracellular matrix" NA NA "HPA044603: AB_10794051" "unprognostic (2.44e-1)" "unprognostic (4.28e-3)" "unprognostic (4.83e-3)" "unprognostic (6.00e-2)" "unprognostic (1.15e-1)" "unprognostic (1.59e-1)" "unprognostic (3.05e-2)" "unprognostic (1.82e-2)" "unprognostic (4.03e-2)" "unprognostic (7.94e-2)" "unprognostic (1.38e-1)" "unprognostic (2.02e-1)" "unprognostic (1.86e-4)" "unprognostic (5.79e-2)" "unprognostic (2.51e-1)" "unprognostic (9.39e-3)" "unprognostic (6.13e-3)" 1.6 0.1 2.0 4.1 9.7 0.1 5.5 2.7 4.2 31.0 3.1 5.4 0.9 3.4 8.0 0.2 17.2 2.3 2.1 0.1 1.7 8.3 1.4 0.1 2.4 0.1 12.2 1.4 0.2 0.1 0.1 0.2 1.7 12.4 12.1 3.2 0.4 1.0 4.9 0.2 1.4 5.1 22.2 11.9 0.1 2.5 2.2 7.6 0.0 0.2 0.2 0.4 12.4 12.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 12.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 23.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.6 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 2.0 9.7 2.7 3.1 1.7 8.3 12.2 1.4 12.4 7.6 0.0 0.0 0.0 4.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 41.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 5.1 1.8 0.1 0.0 0.0 0.0 0.7 LAD1 ENSG00000159166 "Ladinin 1" O00515 1 201373244-201399915 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 83.9;tongue: 66.9" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 171.5;monocytes: 433.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 2.8" "Lineage enriched" "Detected in single" 28 "dendritic cells: 2.8" "Cell line enhanced" "Detected in some" "A-431: 36.7;CAPAN-2: 32.6;HaCaT: 47.4;HBEC3-KT: 36.0;hTCEpi: 35.0;MCF7: 40.2;OE19: 50.5;RT4: 34.6;SK-BR-3: 56.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA007256, HPA028732" Enhanced Enhanced "Actin filaments" "Secreted to extracellular matrix" NA NA "Actin filaments" "HPA007256: AB_1852681, HPA028732: AB_10602916" "unprognostic (4.95e-2)" "unprognostic (2.05e-1)" "unprognostic (3.82e-1)" "unprognostic (7.55e-3)" "unprognostic (4.66e-2)" "unprognostic (7.41e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (1.06e-1)" "unprognostic (1.50e-1)" "unprognostic (1.71e-2)" "unprognostic (9.11e-2)" "unprognostic (2.31e-2)" "unprognostic (3.71e-2)" "unprognostic (1.18e-1)" "unprognostic (6.40e-2)" "unprognostic (3.28e-1)" 0.3 0.2 0.3 10.7 0.3 0.0 3.0 0.3 0.3 15.9 17.5 0.3 22.1 17.4 2.9 4.4 83.9 2.8 56.9 2.0 0.3 0.2 17.2 5.4 3.6 1.5 0.3 0.3 1.5 29.5 0.0 0.4 16.0 0.4 6.9 12.1 0.5 17.1 25.0 1.3 49.7 39.1 1.5 0.3 0.4 13.8 0.6 0.3 3.0 1.6 66.9 42.5 8.9 29.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 36.7 0.3 0.0 0.1 0.0 0.0 11.8 0.0 0.0 0.0 0.0 23.8 32.6 0.0 2.1 0.0 0.0 47.4 0.0 36.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 35.0 0.0 7.2 0.0 0.0 0.0 0.0 0.1 0.0 40.2 0.0 0.1 0.9 50.5 0.4 0.0 1.6 0.4 24.4 34.6 1.9 0.0 0.0 56.7 0.6 1.5 8.5 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.4 0.3 3.0 27.8 1.5 72.1 78.6 0.0 1.8 89.2 4.0 28.4 29.6 0.0 2.9 38.1 140.9 1.0 0.2 171.5 0.0 107.2 4.6 4.1 25.8 0.0 8.5 0.4 0.0 17.4 0.0 0.3 2.4 0.0 2.5 10.1 433.8 49.1 0.0 149.1 89.0 0.4 54.9 0.0 0.0 5.2 0.0 0.0 133.5 8.7 0.0 93.8 117.6 LUM "LDC, SLRR2D" ENSG00000139329 Lumican P51884 12 91102629-91111831 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "placenta: 344.8" "Group enriched" "Detected in many" 8 "Fibroblasts: 1406.2;Leydig cells: 371.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 103 "basophil: 10.2" "Lineage enriched" "Detected in single" 103 "granulocytes: 10.2" "Cell line enriched" "Detected in some" 5 "BJ hTERT+: 186.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001522, CAB025783" Supported "Secreted to extracellular matrix" NA NA 59000000000 "CAB025783: , HPA001522: AB_1079285" "unprognostic (5.54e-2)" "unprognostic (2.27e-1)" "unprognostic (3.32e-1)" "unprognostic (2.75e-1)" "unprognostic (1.65e-1)" "unprognostic (8.38e-2)" "unprognostic (1.09e-1)" "unprognostic (2.87e-1)" "unprognostic (4.08e-2)" "unprognostic (1.19e-1)" "unprognostic (1.65e-2)" "unprognostic (2.20e-2)" "prognostic unfavorable (1.75e-6)" "unprognostic (5.25e-3)" "unprognostic (2.27e-2)" "unprognostic (2.38e-2)" "unprognostic (2.06e-2)" 44.8 25.3 0.8 15.1 0.7 0.0 19.7 0.7 0.7 56.7 26.9 0.7 28.1 5.1 64.8 77.8 28.1 12.2 76.6 48.8 0.8 0.7 26.9 6.4 77.1 32.0 0.9 0.6 73.0 9.1 0.7 2.7 344.8 2.8 77.4 13.3 1.4 5.6 9.9 9.1 8.3 24.0 48.7 4.0 1.3 8.2 30.9 0.3 1.7 18.1 32.3 11.5 65.3 20.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 23.0 11.3 0.0 37.8 186.6 1.5 2.3 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 18.0 0.0 0.0 15.6 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.0 1.6 0.0 0.0 0.0 1.6 0.4 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.7 0.7 0.8 0.7 0.9 0.6 2.8 0.3 11.9 51.4 0.0 1.2 86.7 0.0 10.1 0.0 1.4 9.1 0.0 2.0 47.4 0.0 0.8 2.4 11.6 0.0 0.0 0.0 27.5 1406.2 2.2 17.4 0.4 58.5 0.0 0.0 93.9 0.8 2.9 371.9 3.6 111.3 1.8 0.0 75.5 3.0 0.0 42.1 0.2 2.8 0.0 68.4 0.2 0.9 87.6 70.3 0.0 0.0 4.2 MATN1 "CMP, CRTM" ENSG00000162510 "Matrilin 1, cartilage matrix protein" P21941 1 30711277-30723587 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 6.6" "Cell type enhanced" "Detected in some" 14 "B-cells: 2.7;Club cells: 1.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 3.0" "Group enriched" "Detected in many" 10 "B-cells: 3.0;T-cells: 2.3" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;Karpas-707: 3.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA028580 Supported "Secreted to extracellular matrix" NA NA "HPA028580: AB_10601913" "unprognostic (4.71e-2)" "unprognostic (6.92e-2)" "unprognostic (1.73e-2)" "unprognostic (3.75e-6)" "unprognostic (9.93e-2)" "unprognostic (4.10e-1)" "unprognostic (1.31e-3)" "unprognostic (2.63e-1)" "unprognostic (1.32e-1)" "unprognostic (2.80e-1)" "unprognostic (7.31e-2)" "unprognostic (5.22e-2)" "unprognostic (4.01e-13)" "unprognostic (8.23e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-2)" "unprognostic (3.42e-2)" 0.4 0.4 1.1 1.0 0.7 2.6 0.4 0.4 1.7 2.0 0.4 0.4 0.4 0.3 1.7 0.6 0.4 0.9 0.7 0.4 1.2 1.1 0.4 0.4 6.6 2.0 1.1 0.4 2.9 0.6 0.0 1.1 1.1 0.4 0.5 0.0 0.4 1.4 0.4 0.4 0.9 0.5 0.4 1.4 1.4 0.5 1.0 0.4 0.4 1.4 0.4 0.4 0.5 1.2 3.0 0.1 0.2 0.1 0.0 2.3 0.6 0.9 0.5 0.2 1.0 0.2 0.0 0.3 0.5 0.2 0.1 0.0 0.1 1.5 0.7 3.5 0.1 0.7 1.3 0.2 0.1 0.2 1.5 0.4 1.3 1.0 0.1 0.0 0.4 1.0 0.0 0.0 0.0 0.9 0.6 0.0 0.4 2.0 3.5 0.0 1.4 0.1 0.2 0.2 0.3 1.0 0.5 1.4 0.5 0.0 0.4 0.4 0.6 0.5 0.4 0.8 0.6 0.4 1.2 0.6 0.3 0.8 0.2 0.8 0.9 0.1 0.3 0.0 0.6 2.1 0.0 0.1 0.0 0.5 0.0 0.9 0.9 0.6 0.5 0.0 3.0 2.3 1.2 0.2 0.0 0.0 0.1 0.8 0.6 1.1 0.7 0.4 1.7 1.2 1.1 1.1 0.4 0.4 0.4 0.0 0.3 2.7 0.5 0.1 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 0.5 0.1 0.2 0.0 0.0 0.1 MATN2 ENSG00000132561 "Matrilin 2" O00339 8 97868840-98036716 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Ito cells: 119.7;Leydig cells: 95.8;Peritubular cells: 243.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 9.0" "Lineage enriched" "Detected in many" 7 "T-cells: 9.0" "Cell line enhanced" "Detected in many" "ASC diff: 20.4;BJ: 23.3;BJ hTERT+ SV40 Large T+: 25.9;BJ hTERT+ SV40 Large T+ RasG12V: 35.5;HaCaT: 36.9;HBF TERT88: 33.5;SuSa: 23.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB033879 Approved "Secreted to extracellular matrix" NA NA 600000 "CAB033879: AB_2141502" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (9.99e-2)" "unprognostic (2.14e-1)" "unprognostic (4.98e-1)" "unprognostic (5.35e-2)" "unprognostic (7.18e-2)" "unprognostic (5.22e-2)" "unprognostic (2.77e-1)" "unprognostic (2.07e-3)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (2.04e-2)" "unprognostic (1.69e-1)" "unprognostic (6.31e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (6.65e-2)" 11.9 11.8 20.7 15.4 12.3 0.0 12.1 5.4 9.0 56.4 21.7 11.4 30.2 12.9 49.7 24.2 9.1 14.2 23.0 36.1 10.4 4.9 10.7 6.3 4.3 6.1 15.5 4.0 39.8 3.2 1.2 3.8 39.5 11.7 43.0 13.2 5.8 11.9 41.6 1.6 13.8 36.9 40.4 9.0 1.4 8.3 10.6 13.0 0.6 63.3 9.2 3.6 27.9 47.8 0.4 1.2 0.1 0.8 0.2 9.0 0.2 7.5 3.4 7.6 0.8 20.4 1.2 4.9 23.3 5.7 25.9 35.5 4.0 2.7 0.0 2.3 9.3 1.1 36.9 0.7 1.4 33.5 0.0 0.9 0.2 2.0 0.2 4.7 0.0 0.0 4.5 3.1 5.3 0.2 7.3 0.1 0.4 0.0 0.0 1.3 3.5 0.0 0.2 2.3 0.0 1.2 0.0 0.8 3.5 1.8 1.7 5.2 0.5 3.7 0.0 6.0 23.2 3.5 0.4 0.2 1.7 10.8 5.2 3.5 0.3 0.0 0.0 6.2 0.1 1.9 0.0 0.2 0.1 0.3 0.8 9.0 0.1 1.2 1.6 1.2 0.4 0.1 0.1 0.0 0.2 0.0 0.3 0.0 0.2 20.7 12.3 5.4 9.0 10.4 4.9 15.5 4.0 11.7 13.0 3.0 2.2 0.0 10.9 33.2 5.8 24.8 20.4 1.4 3.4 15.7 51.1 1.2 0.0 8.0 77.0 22.7 18.7 0.0 0.0 0.9 57.2 5.6 0.0 7.8 1.3 0.0 22.5 119.7 5.7 77.1 95.8 1.2 27.0 2.8 22.4 5.6 1.9 18.7 243.3 3.8 43.8 12.9 8.2 1.9 1.4 7.4 2.1 2.5 23.0 1.5 MATN3 "EDM5, HOA" ENSG00000132031 "Matrilin 3" O15232 2 19992111-20012694 "Disease related genes, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 19.5;placenta: 16.6" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 35.7;Sertoli cells: 25.8;Smooth muscle cells: 11.4" "Cancer enhanced" "Detected in all" "pancreatic cancer: 13.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "Hep G2: 56.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA051250 Approved "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" NA NA "Endoplasmic reticulum, Golgi apparatus" "HPA051250: AB_2681406" "unprognostic (3.47e-1)" "prognostic unfavorable (1.41e-4)" "unprognostic (7.57e-2)" "unprognostic (2.75e-2)" "unprognostic (1.71e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.62e-5)" "unprognostic (1.27e-1)" "unprognostic (4.84e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.54e-2)" "unprognostic (2.11e-2)" "prognostic unfavorable (4.74e-5)" "unprognostic (2.51e-1)" "unprognostic (7.04e-2)" "unprognostic (3.15e-2)" 2.4 1.3 6.6 1.0 5.1 0.3 3.4 1.8 7.9 4.1 1.0 2.4 2.6 0.9 2.7 1.8 1.4 2.6 3.4 0.9 6.2 4.9 4.1 0.4 19.5 0.7 8.6 3.7 1.1 1.3 0.4 0.3 16.6 7.4 2.7 1.0 1.9 0.8 7.2 0.5 0.9 0.8 2.8 7.9 0.7 2.8 1.6 6.0 0.0 1.7 0.0 0.7 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 1.9 6.5 0.0 1.9 4.1 0.4 0.8 0.4 2.6 3.4 1.8 1.1 0.0 0.3 0.6 2.5 0.4 0.1 5.0 3.8 0.0 0.1 0.0 0.4 56.1 0.4 0.0 0.0 8.8 0.3 2.9 0.7 1.8 3.5 0.0 0.0 0.0 5.5 0.9 0.0 0.0 2.0 0.0 0.9 0.0 0.0 0.0 7.9 1.7 0.0 0.8 4.2 0.7 2.4 11.6 7.7 0.0 1.9 3.9 4.8 0.1 0.4 0.0 0.0 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 5.1 1.8 7.9 6.2 4.9 8.6 3.7 7.4 6.0 35.7 2.1 0.0 0.3 0.2 0.0 0.2 0.0 2.7 2.3 1.8 0.0 0.0 0.0 0.2 0.4 1.4 0.0 0.0 0.2 1.6 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.3 0.0 0.0 0.0 0.7 0.0 4.2 0.3 0.0 25.8 11.4 0.0 1.5 0.1 0.1 0.0 0.0 0.1 MATN4 ENSG00000124159 "Matrilin 4" O95460 20 45293445-45308529 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "ductus deferens: 21.5;pancreas: 27.1;seminal vesicle: 17.7" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 5.7;Exocrine glandular cells: 2.3;Spermatogonia: 3.8;Suprabasal keratinocytes: 3.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 3.1;NB-4: 7.0;SK-MEL-30: 2.3;U-937: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "unprognostic (1.54e-1)" "unprognostic (2.39e-2)" "unprognostic (2.22e-2)" "unprognostic (3.60e-2)" "unprognostic (8.38e-2)" "unprognostic (9.67e-2)" "unprognostic (1.84e-1)" "unprognostic (6.79e-2)" "unprognostic (6.27e-2)" "unprognostic (6.74e-3)" "unprognostic (5.53e-1)" "unprognostic (6.19e-3)" "unprognostic (3.63e-6)" "unprognostic (2.38e-1)" "unprognostic (4.69e-2)" "unprognostic (4.27e-1)" "unprognostic (5.38e-2)" 0.6 0.0 0.1 0.0 0.2 0.1 2.4 0.0 0.2 1.4 0.0 0.0 21.5 0.0 0.6 0.6 0.2 0.1 0.1 1.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.3 0.0 0.1 0.2 0.0 1.9 1.5 17.7 0.0 4.1 0.0 0.0 0.3 0.0 0.4 1.6 0.0 0.2 0.1 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.1 0.4 0.4 3.1 0.4 0.1 0.3 0.3 0.0 0.0 0.0 1.0 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.4 0.0 7.0 0.3 0.0 1.0 0.0 0.1 0.0 0.3 0.2 0.5 0.0 0.1 0.3 2.3 0.0 0.1 0.6 0.0 0.2 1.0 0.0 0.1 0.1 0.6 0.2 0.2 3.5 0.7 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 5.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 2.3 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 1.4 3.8 3.8 0.2 0.0 0.0 0.9 MFAP2 "MAGP, MAGP-1" ENSG00000117122 "Microfibril associated protein 2" P55001 1 16974502-16980835 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 51.7" "Cell type enhanced" "Detected in many" 15 "Extravillous trophoblasts: 148.9;Fibroblasts: 84.5;Leydig cells: 49.8;Peritubular cells: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "gdT-cell: 2.1" "Lineage enriched" "Detected in single" 7 "T-cells: 2.1" "Cell line enhanced" "Detected in many" "ASC diff: 48.7;ASC TERT1: 50.2;HUVEC TERT2: 51.4;SH-SY5Y: 43.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007354 Enhanced "Secreted to extracellular matrix" NA NA "HPA007354: AB_1079365" "unprognostic (5.10e-2)" "unprognostic (3.81e-2)" "unprognostic (2.62e-1)" "unprognostic (2.92e-2)" "unprognostic (4.86e-1)" "unprognostic (1.53e-3)" "unprognostic (3.72e-3)" "unprognostic (2.21e-1)" "unprognostic (1.85e-2)" "unprognostic (1.98e-1)" "unprognostic (9.45e-3)" "unprognostic (9.12e-2)" "prognostic unfavorable (2.52e-8)" "unprognostic (2.18e-3)" "unprognostic (1.34e-1)" "unprognostic (1.93e-1)" "unprognostic (5.66e-3)" 13.1 1.6 0.2 6.0 0.4 0.0 20.8 0.4 0.8 24.8 5.0 0.5 6.7 1.6 28.7 14.0 5.7 6.6 29.7 29.6 0.6 0.3 3.4 0.8 12.5 1.2 0.3 1.0 23.6 33.9 0.0 4.7 51.7 1.8 16.9 1.7 15.4 6.9 5.0 4.6 10.9 4.3 18.3 2.9 1.3 3.5 10.4 0.3 0.7 3.8 7.4 3.3 10.3 13.2 0.3 0.0 0.0 0.1 0.0 2.1 0.2 0.0 0.0 19.0 0.0 48.7 50.2 1.2 4.8 20.0 7.5 14.7 4.3 0.2 0.0 16.6 16.7 0.0 0.0 1.3 1.5 3.0 0.0 14.8 0.0 7.0 0.4 4.6 0.0 0.0 20.5 3.7 21.1 8.4 23.3 51.4 0.0 0.0 3.1 3.7 2.3 0.0 0.0 22.1 0.1 0.1 0.2 0.0 0.6 0.2 0.0 1.0 43.1 1.6 7.2 1.8 15.6 2.4 2.5 14.2 13.1 27.4 10.6 0.5 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.4 0.8 0.6 0.3 0.3 1.0 1.8 0.3 0.0 1.7 0.0 5.7 6.0 0.0 0.4 2.5 1.4 7.9 3.5 0.0 3.9 0.0 0.9 13.1 0.6 0.0 0.0 0.7 148.9 84.5 1.0 0.0 0.0 6.7 0.0 9.7 1.8 0.0 4.5 49.8 0.9 16.9 0.0 0.3 26.5 3.2 0.0 60.1 0.0 0.8 0.0 4.1 1.1 8.1 5.5 24.3 0.0 0.0 0.8 MFAP5 "MAGP2, MP25" ENSG00000197614 "Microfibril associated protein 5" Q13361 12 8637346-8662888 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aortic aneurysm, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.1" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 937.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 50.0;BJ: 18.1;EFO-21: 43.9;HeLa: 16.6;SuSa: 42.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA010553 Enhanced "Secreted to extracellular matrix" NA NA 3800000 "HPA010553: AB_1853843" "unprognostic (1.80e-1)" "unprognostic (1.11e-2)" "unprognostic (4.25e-2)" "unprognostic (4.84e-2)" "unprognostic (1.44e-1)" "unprognostic (6.05e-2)" "unprognostic (2.15e-3)" "unprognostic (1.10e-1)" "unprognostic (1.64e-1)" "unprognostic (8.79e-2)" "unprognostic (8.63e-3)" "unprognostic (3.05e-1)" "unprognostic (4.41e-7)" "prognostic unfavorable (6.87e-4)" "unprognostic (8.81e-2)" "unprognostic (2.05e-2)" "prognostic unfavorable (5.81e-4)" 44.3 3.2 0.6 3.3 0.7 0.3 21.8 0.5 0.5 71.5 11.2 0.5 18.2 1.4 78.4 34.0 31.3 9.0 6.8 16.5 0.7 0.6 1.9 3.0 3.3 3.3 0.6 0.4 4.7 1.4 0.2 1.7 128.1 0.7 7.6 11.0 0.9 6.0 13.5 19.6 13.0 9.0 37.0 3.4 1.0 7.9 12.3 0.3 1.0 13.1 35.0 4.5 46.3 21.1 1.1 1.2 5.3 2.4 0.6 1.2 0.8 0.4 1.6 0.4 0.7 8.7 3.7 50.0 18.1 0.3 0.2 0.3 0.6 0.3 0.1 43.9 5.6 0.4 2.5 0.1 3.7 0.0 0.1 0.1 0.4 16.6 0.5 0.1 0.3 0.2 2.5 1.3 2.1 0.0 0.9 0.0 0.5 0.7 1.0 15.1 0.2 0.5 0.2 0.9 0.2 0.8 0.3 0.4 1.8 1.8 0.7 0.2 0.2 0.5 0.2 0.3 42.1 6.9 0.2 0.6 3.2 6.3 13.2 0.8 0.6 0.5 0.5 1.7 0.2 0.0 5.3 2.4 2.0 0.7 1.9 1.2 0.4 0.4 0.4 1.2 1.1 1.2 0.5 3.1 0.6 1.4 1.0 0.1 0.8 0.6 0.7 0.5 0.5 0.7 0.6 0.6 0.4 0.7 0.3 11.9 4.3 0.0 0.4 20.5 0.2 5.2 0.0 2.7 3.4 0.0 0.0 70.9 0.0 0.0 0.3 4.4 0.0 0.0 0.0 937.0 96.1 0.0 0.0 0.0 24.9 0.0 0.0 7.4 1.9 0.2 56.7 3.6 11.8 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.6 0.0 20.2 0.0 0.0 15.7 210.9 0.0 0.0 0.1 MMRN1 "ECM, EMILIN4, GPIa*, MMRN" ENSG00000138722 "Multimerin 1" Q13201 4 89879532-89954629 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Endothelial cells: 46.9;Ito cells: 114.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "NK-cell: 9.3;plasmacytoid DC: 3.4" "Group enriched" "Detected in many" 7 "dendritic cells: 3.4;NK-cells: 9.3" "Cell line enriched" "Detected in some" 13 "HUVEC TERT2: 168.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA035769 Enhanced Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 300000000 "Endoplasmic reticulum" "HPA035769: AB_10696511" "unprognostic (1.15e-1)" "unprognostic (1.81e-2)" "unprognostic (1.23e-1)" "unprognostic (2.41e-1)" "unprognostic (2.11e-1)" "unprognostic (7.05e-3)" "unprognostic (1.62e-3)" "unprognostic (1.91e-1)" "unprognostic (1.88e-1)" "unprognostic (2.12e-1)" "unprognostic (9.71e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.77e-4)" "prognostic unfavorable (5.46e-4)" "unprognostic (2.14e-1)" "unprognostic (1.36e-1)" "unprognostic (2.23e-2)" 13.9 1.9 1.4 5.3 1.4 0.5 14.8 0.7 1.3 22.8 14.9 0.1 9.0 2.6 9.2 12.2 17.4 18.1 11.5 4.9 1.6 1.3 3.3 9.5 22.4 30.7 2.6 0.0 10.2 2.2 0.1 1.3 38.1 2.7 10.0 8.1 3.7 3.3 2.4 6.8 6.5 10.1 14.2 3.4 1.6 5.3 16.7 2.1 2.3 43.1 7.0 3.7 19.6 30.4 0.8 3.4 0.1 0.0 9.3 0.3 1.7 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 168.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.8 0.3 0.0 0.1 9.3 0.0 3.4 0.3 1.7 1.4 1.4 0.7 1.3 1.6 1.3 2.6 0.0 2.7 2.1 0.0 11.8 6.1 0.1 3.8 0.0 2.0 0.0 2.7 1.2 0.0 0.0 0.0 1.7 0.0 11.8 46.9 0.0 0.0 0.0 0.0 1.5 0.1 2.3 0.8 0.4 0.0 0.0 114.2 6.3 3.2 0.3 2.5 1.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 1.4 1.7 0.0 4.0 0.0 0.0 0.0 0.1 MUC20 "FLJ14408, KIAA1359" ENSG00000176945 "Mucin 20, cell surface associated" Q8N307 3 195720882-195741123 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 50.6" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 60.2;Urothelial cells: 102.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 25.3" HPA042249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 11000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042249: " "unprognostic (1.85e-1)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.83e-3)" "unprognostic (2.12e-1)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.41e-1)" "unprognostic (3.99e-4)" "unprognostic (7.66e-2)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.57e-4)" "unprognostic (2.05e-1)" "unprognostic (2.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.17e-1)" 1.7 1.2 1.1 3.4 2.1 1.2 1.8 2.5 1.2 6.3 15.2 1.1 4.7 3.2 1.5 5.2 15.9 5.7 8.7 1.1 1.1 0.7 50.6 4.8 6.4 1.1 1.1 1.1 4.6 7.6 1.0 4.6 13.3 1.1 4.9 7.6 1.2 10.6 1.8 2.5 2.1 4.1 2.0 1.1 1.6 2.3 1.8 1.1 3.0 3.9 1.9 14.9 10.6 26.6 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.6 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 3.0 0.1 0.5 0.0 0.2 1.3 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.5 3.4 0.1 0.8 0.1 0.8 0.0 1.9 1.0 0.3 0.0 25.3 0.2 0.4 0.1 0.0 0.0 0.2 0.7 0.9 0.1 1.1 1.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.1 2.5 1.2 1.1 0.7 1.1 1.1 1.1 1.1 32.8 14.7 0.0 8.8 1.5 20.2 0.5 10.2 60.2 37.5 21.0 33.4 0.0 1.7 32.3 0.0 1.3 15.6 0.0 8.7 0.1 1.5 12.8 1.1 6.4 0.4 11.1 13.3 1.8 0.6 0.0 4.9 0.9 3.3 0.0 7.2 5.6 13.7 18.6 6.0 1.4 22.0 0.0 1.6 1.1 0.7 1.6 0.0 0.5 13.5 102.7 MYOC "GLC1A, JOAG1, TIGR" ENSG00000034971 Myocilin Q99972 1 171635417-171652683 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Disease mutation, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 100.8" "Cell type enriched" "Detected in some" 4 "Peritubular cells: 35.3" "Cancer enriched" "Detected in many" 6 "melanoma: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027364 Uncertain "Secreted to extracellular matrix" NA NA 12000000 "HPA027364: AB_10602036" "unprognostic (2.02e-2)" "unprognostic (4.65e-2)" "unprognostic (4.44e-2)" "unprognostic (6.29e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-2)" "unprognostic (3.42e-2)" "unprognostic (3.02e-2)" "unprognostic (2.82e-2)" "unprognostic (2.54e-1)" "unprognostic (1.94e-4)" "unprognostic (5.35e-2)" "unprognostic (1.87e-1)" "unprognostic (3.87e-2)" "unprognostic (1.24e-1)" 26.9 0.8 0.0 0.5 0.0 0.0 8.4 0.0 0.0 5.4 6.0 0.0 5.3 2.4 8.1 7.6 40.7 7.4 8.3 12.6 0.1 0.0 0.2 0.1 3.7 0.0 0.0 0.0 3.9 2.1 0.2 0.1 0.1 0.2 9.0 2.5 100.8 10.5 4.8 21.7 2.4 2.6 39.4 0.3 0.1 29.9 2.8 0.0 0.6 14.9 28.2 5.0 26.1 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.3 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 NTN4 ENSG00000074527 "Netrin 4" Q9HB63 12 95657807-95791152 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 76.9" "Cell type enhanced" "Detected in many" 15 "Collecting duct cells: 188.5;Ito cells: 457.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 49 "T-cells: 4.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 94.4;hTERT-HME1: 39.1;PC-3: 35.7;TIME: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049832 Approved "Secreted to extracellular matrix" NA NA "HPA049832: AB_2680905" "unprognostic (3.08e-1)" "unprognostic (2.17e-1)" "unprognostic (2.33e-1)" "unprognostic (4.15e-2)" "unprognostic (2.11e-2)" "unprognostic (1.42e-1)" "unprognostic (1.67e-1)" "unprognostic (3.03e-2)" "unprognostic (8.71e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (9.50e-4)" "unprognostic (2.85e-1)" "prognostic favorable (8.12e-9)" "unprognostic (3.52e-2)" "unprognostic (7.08e-2)" "unprognostic (1.93e-1)" "prognostic favorable (6.67e-5)" 11.1 8.5 4.0 4.4 6.3 0.0 22.8 1.2 9.0 9.9 8.9 2.5 7.3 3.4 8.2 11.9 10.7 10.7 13.0 27.2 3.9 2.4 35.8 13.6 21.7 0.7 4.1 6.1 28.5 18.2 6.6 4.5 7.7 2.8 24.1 5.4 8.4 14.7 19.6 7.2 3.8 8.7 7.2 2.2 76.9 14.5 6.5 2.2 1.5 6.7 9.7 4.2 14.1 11.9 0.0 0.0 0.0 0.0 0.0 4.9 0.0 4.8 13.3 0.3 0.0 5.4 8.7 0.5 9.2 94.4 12.6 15.1 10.4 9.2 0.0 0.6 19.5 17.2 7.7 0.1 2.7 6.4 0.0 0.8 0.4 2.4 2.0 0.3 0.0 0.0 0.2 8.1 14.5 39.1 13.9 24.7 0.0 0.0 0.0 4.7 3.6 0.0 0.0 0.2 1.4 35.7 0.0 0.1 0.0 12.2 24.8 0.0 0.1 11.2 14.4 0.2 0.4 4.2 0.0 53.7 4.9 1.8 19.1 0.9 0.0 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.0 6.3 1.2 9.0 3.9 2.4 4.1 6.1 2.8 2.2 38.7 99.7 15.7 94.2 4.1 1.9 36.7 40.8 14.7 17.0 188.5 0.0 3.8 5.0 34.9 7.2 20.0 1.7 0.0 24.2 2.0 15.0 61.0 1.1 6.8 0.3 0.0 0.0 457.9 41.5 3.1 2.0 2.5 6.8 1.0 41.2 0.2 37.2 2.9 3.2 38.3 0.0 25.8 33.3 1.9 0.5 1.9 1.4 4.9 5.3 78.5 PCOLCE "PCPE, PCPE1" ENSG00000106333 "Procollagen C-endopeptidase enhancer" Q15113 7 100602177-100608175 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 16 "Fibroblasts: 347.3;Leydig cells: 130.0;Smooth muscle cells: 134.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 85.2;BJ hTERT+: 63.5;HSkMC: 97.7;SH-SY5Y: 68.1;U-138 MG: 39.4;U-2197: 120.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017623, HPA042927" Approved Approved "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 1300000000 "Golgi apparatus, Vesicles" "CAB017623: AB_2251882, HPA042927: AB_2678224" "unprognostic (4.14e-1)" "unprognostic (1.79e-1)" "unprognostic (1.34e-1)" "unprognostic (2.92e-1)" "unprognostic (1.70e-2)" "unprognostic (4.48e-2)" "unprognostic (1.33e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.16e-2)" "unprognostic (1.73e-1)" "unprognostic (6.13e-2)" "prognostic unfavorable (1.68e-5)" "unprognostic (1.04e-2)" "unprognostic (3.21e-2)" "unprognostic (1.63e-2)" "unprognostic (1.43e-2)" 29.5 16.7 0.6 18.1 1.3 0.0 29.3 1.0 2.0 90.4 11.2 1.6 22.8 2.0 42.1 89.9 23.1 29.6 34.3 47.3 0.7 0.7 14.6 73.0 24.5 51.1 3.7 1.9 38.8 7.9 1.2 11.4 23.8 2.9 49.4 4.5 54.6 16.0 19.8 10.0 16.0 7.4 26.1 6.9 10.5 9.1 20.8 0.5 2.4 17.8 20.1 18.4 28.2 34.0 0.8 1.0 1.6 1.0 1.1 1.1 0.1 0.0 0.0 0.1 0.2 30.1 85.2 0.2 34.9 63.5 15.8 13.9 1.3 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 1.3 0.2 0.2 0.0 0.5 1.7 8.4 0.0 0.2 97.7 0.0 8.3 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.1 0.0 0.2 7.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 68.1 0.0 0.1 0.1 0.7 0.1 0.0 0.2 39.4 10.9 120.2 0.0 0.0 0.0 0.0 13.7 0.0 6.6 0.0 0.3 1.6 0.5 1.0 1.1 0.8 0.9 0.6 1.0 0.2 0.6 0.3 0.4 1.1 0.8 0.0 0.4 0.1 0.6 1.3 1.0 2.0 0.7 0.7 3.7 1.9 2.9 0.5 8.9 3.2 0.8 2.9 35.5 3.0 15.7 2.5 4.0 5.7 5.2 0.0 13.9 23.2 5.0 10.4 10.5 0.0 0.0 4.5 10.7 347.3 1.6 1.1 16.1 18.8 15.9 1.7 53.4 1.3 18.5 130.0 4.4 30.4 0.0 0.7 10.8 4.7 0.2 47.4 1.9 1.6 32.3 134.4 21.6 14.0 29.0 21.1 7.2 0.4 2.6 PODN "MGC24995, PCAN, PODOCAN, SLRR5A" ENSG00000174348 Podocan Q7Z5L7 1 53062052-53085502 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Leydig cells: 248.8;Peritubular cells: 245.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "gdT-cell: 8.5;memory CD8 T-cell: 2.4;naive CD8 T-cell: 2.7" "Lineage enriched" "Detected in single" 85 "T-cells: 8.5" "Cell line enhanced" "Detected in some" "ASC diff: 10.5;BJ: 17.4;fHDF/TERT166: 10.3;HHSteC: 43.1;HSkMC: 6.8;U-2197: 21.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA 190000 "unprognostic (8.69e-2)" "unprognostic (4.73e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.46e-1)" "unprognostic (4.51e-2)" "unprognostic (2.31e-1)" "unprognostic (1.88e-1)" "unprognostic (3.65e-1)" "unprognostic (1.90e-3)" "unprognostic (1.71e-1)" "unprognostic (3.53e-2)" "prognostic unfavorable (2.02e-5)" "unprognostic (5.91e-3)" "unprognostic (1.62e-1)" "unprognostic (6.11e-2)" "unprognostic (5.02e-2)" 39.0 4.1 2.1 15.2 1.5 0.0 48.1 1.1 1.3 33.4 23.5 1.0 21.5 4.6 29.1 57.8 28.4 29.0 96.8 32.3 1.7 1.2 3.3 4.0 18.5 4.0 2.6 0.7 65.7 8.4 1.4 5.2 7.2 3.0 47.1 3.4 6.1 10.9 15.0 14.0 10.9 7.5 46.5 3.4 1.0 20.4 35.5 1.6 4.4 19.6 19.4 4.3 50.5 55.1 0.0 0.0 0.0 0.0 0.0 8.5 1.1 0.0 0.0 0.0 0.0 10.5 1.4 0.0 17.4 2.3 0.2 0.1 0.0 0.0 0.0 0.3 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.1 0.0 0.0 6.8 0.0 0.4 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.6 2.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 1.1 2.1 1.5 1.1 1.3 1.7 1.2 2.6 0.7 3.0 1.6 0.0 3.5 0.0 0.4 5.7 0.1 1.2 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.4 42.1 0.4 0.0 0.0 0.5 0.0 0.0 7.4 0.0 4.0 248.8 1.1 5.0 0.0 0.0 0.2 0.0 0.0 245.4 0.0 0.5 0.0 13.2 0.6 0.6 5.3 0.5 0.0 0.0 0.1 PRELP "prolargin, SLRR2A" ENSG00000188783 "Proline and arginine rich end leucine rich repeat protein" P51888 1 203475828-203491352 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 183.7" "Group enriched" "Detected in many" 4 "Fibroblasts: 65.7;Leydig cells: 93.2;Melanocytes: 182.2;Muller glia cells: 156.5;Peritubular cells: 187.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "ASC diff: 18.7;BJ: 7.6;fHDF/TERT166: 11.5;SuSa: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA 280000 "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "prognostic unfavorable (9.70e-5)" "unprognostic (2.83e-2)" "unprognostic (6.56e-2)" "unprognostic (2.75e-2)" "unprognostic (1.61e-1)" "unprognostic (2.84e-2)" "unprognostic (3.98e-2)" "unprognostic (2.04e-1)" "unprognostic (2.80e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (5.62e-6)" "unprognostic (2.81e-2)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (1.02e-4)" 46.7 16.0 6.3 7.7 5.8 1.1 52.3 3.6 5.0 57.4 35.7 3.7 16.8 5.0 45.3 17.8 46.2 29.5 27.4 58.6 7.0 1.8 8.1 7.3 49.9 5.2 6.4 9.5 62.3 6.6 1.8 7.3 8.3 8.6 48.3 6.6 64.6 10.4 52.5 24.5 16.4 17.0 61.8 7.7 22.6 13.5 23.4 3.3 0.0 25.1 16.1 11.5 98.7 183.7 1.0 1.0 4.0 1.2 1.1 0.8 0.6 0.2 0.2 0.5 0.2 18.7 0.5 0.5 7.6 1.0 0.2 0.2 0.0 0.2 1.2 0.7 11.5 0.2 0.7 0.2 0.3 0.3 0.1 0.2 0.4 0.4 0.2 0.0 0.3 0.2 0.0 0.1 0.1 0.2 2.1 0.1 0.4 0.3 0.5 1.4 0.1 0.2 0.5 0.5 0.3 0.1 0.4 0.2 0.5 0.0 0.3 1.1 0.3 0.2 0.2 0.8 5.6 0.3 0.2 0.6 0.5 0.3 0.3 0.1 0.3 0.4 1.2 0.1 0.2 0.5 4.0 1.2 1.7 0.7 1.0 0.8 0.6 0.7 0.5 0.4 1.0 0.7 0.6 2.7 1.1 1.1 1.0 0.6 0.6 6.3 5.8 3.6 5.0 7.0 1.8 6.4 9.5 8.6 3.3 0.0 8.0 0.5 0.9 16.3 2.9 4.3 0.0 2.7 1.2 0.0 2.0 0.0 0.0 0.0 0.6 10.9 0.0 0.0 0.0 0.1 65.7 0.5 4.7 0.0 0.3 1.6 0.0 30.7 0.0 2.3 93.2 1.9 182.2 0.0 0.0 156.5 0.0 0.0 187.7 0.0 4.7 25.8 26.8 2.7 0.8 8.7 0.2 0.0 0.0 0.7 PRG4 "bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP" ENSG00000116690 "Proteoglycan 4" Q92954 1 186296279-186314562 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 20.9;liver: 76.0" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 298.2" "Cancer enriched" "Detected in many" 10 "liver cancer: 28.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "T-reg: 4.0" "Lineage enriched" "Detected in single" 33 "T-cells: 4.0" "Cell line enriched" "Detected in some" 7 "ASC diff: 81.7" "Low region specificity" "Detected in many" HPA028523 Uncertain "Secreted to extracellular matrix" NA NA 4300000000 "HPA028523: AB_10669642" "unprognostic (8.67e-2)" "unprognostic (2.28e-1)" "unprognostic (1.82e-3)" "unprognostic (1.98e-1)" "unprognostic (1.77e-1)" "unprognostic (7.87e-2)" "unprognostic (7.33e-2)" "unprognostic (1.78e-1)" "unprognostic (1.28e-1)" "unprognostic (1.53e-1)" "unprognostic (5.03e-2)" "unprognostic (4.11e-1)" "unprognostic (1.91e-13)" "unprognostic (1.40e-2)" "unprognostic (2.60e-1)" "unprognostic (1.60e-3)" "unprognostic (7.05e-3)" 20.9 0.7 0.1 1.0 0.1 0.2 5.1 0.2 0.3 0.2 2.8 0.4 0.1 0.1 0.2 1.7 0.9 6.8 0.3 11.0 0.1 0.3 0.2 76.0 7.2 0.3 0.3 0.1 0.7 1.1 0.1 0.3 0.1 0.3 0.3 0.2 2.6 1.0 0.2 13.8 1.6 0.2 0.7 0.1 0.3 0.2 1.1 0.1 0.2 0.7 1.9 0.3 0.7 0.1 0.1 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 81.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.5 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 4.0 0.1 0.1 0.1 0.2 0.3 0.1 0.3 0.3 0.1 0.3 0.1 20.8 14.4 8.2 0.0 0.6 0.0 0.8 7.6 20.1 38.7 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 2.2 0.1 15.1 298.2 0.1 0.0 0.0 7.4 8.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.5 0.0 0.1 RPTN FLJ39117 ENSG00000215853 Repetin Q6XPR3 1 152153595-152159228 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 33.2;skin 1: 19.5;tongue: 71.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 3.7;hTCEpi: 1.9" "HPA030483, HPA030485" Enhanced "Secreted to extracellular matrix" NA NA "HPA030483: AB_2673495, HPA030485: AB_10601159" "unprognostic (1.37e-2)" "unprognostic (5.06e-2)" "unprognostic (2.35e-1)" "unprognostic (4.54e-2)" "unprognostic (4.00e-2)" "unprognostic (5.23e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 71.0 33.2 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 SBSPON "C8orf84, RPESP" ENSG00000164764 "Somatomedin B and thrombospondin type 1 domain containing" Q8IVN8 8 73064540-73124088 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 66.7;urinary bladder: 47.9" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 40.1;Muller glia cells: 43.4;Peritubular cells: 25.1;Smooth muscle cells: 30.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 10.0;RPTEC TERT1: 18.1;SuSa: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029595 Approved Approved Vesicles "Secreted to extracellular matrix" NA NA 19000 Vesicles "HPA029595: AB_10600763" "prognostic favorable (7.18e-4)" "unprognostic (5.08e-3)" "unprognostic (3.24e-1)" "unprognostic (4.41e-2)" "unprognostic (1.75e-1)" "unprognostic (2.31e-1)" "unprognostic (2.78e-2)" "unprognostic (8.65e-2)" "unprognostic (2.92e-1)" "unprognostic (1.46e-1)" "unprognostic (9.54e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (8.82e-4)" "unprognostic (6.14e-2)" "unprognostic (3.54e-1)" "unprognostic (2.12e-2)" "unprognostic (6.25e-2)" 6.7 3.0 0.6 1.7 0.7 0.3 6.7 2.6 0.7 6.5 4.2 2.9 16.5 0.8 4.9 18.1 9.6 8.2 3.0 3.5 1.1 0.8 14.4 0.6 5.0 2.4 2.5 0.9 9.0 1.2 0.0 1.7 9.3 5.4 19.4 1.1 4.3 4.3 25.4 1.1 1.8 2.6 66.7 15.7 1.1 9.9 5.6 0.7 0.1 3.2 2.5 0.9 47.9 7.6 0.9 1.2 1.1 0.4 1.5 0.8 0.3 0.3 0.2 0.5 0.6 0.0 0.0 1.4 10.0 0.0 0.0 0.0 0.1 0.2 0.4 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.4 0.4 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.3 0.0 0.0 0.4 0.3 1.0 0.5 0.2 0.2 0.2 0.0 18.1 0.1 0.6 0.5 1.1 0.4 0.1 3.6 0.2 0.1 0.5 0.2 1.7 0.2 0.2 0.1 0.0 0.1 0.2 0.2 0.2 0.7 0.4 0.4 0.6 0.0 0.1 0.4 0.6 0.7 0.1 0.9 0.4 0.8 1.1 1.5 0.4 1.2 0.2 0.3 0.6 0.7 2.6 0.7 1.1 0.8 2.5 0.9 5.4 0.7 8.9 0.0 0.0 4.1 1.1 2.6 1.1 7.6 0.0 0.0 40.1 2.0 0.2 1.7 1.0 5.8 1.5 0.0 0.0 0.0 0.2 14.3 1.6 0.0 0.0 0.4 0.0 0.0 0.6 0.0 1.6 11.2 0.0 3.3 0.0 0.0 43.4 0.8 0.0 25.1 0.7 1.8 6.5 30.8 10.3 2.1 1.1 0.3 0.0 0.0 0.3 SMOC2 SMAP2 ENSG00000112562 "SPARC related modular calcium binding 2" Q9H3U7 6 168441151-168673445 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Leydig cells: 298.0;Peritubular cells: 723.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "naive B-cell: 3.3" "Lineage enriched" "Detected in single" 7 "B-cells: 3.3" "Cell line enhanced" "Detected in some" "AF22: 9.5;EFO-21: 3.3;RPMI-8226: 12.6;RPTEC TERT1: 4.5;SuSa: 11.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (3.23e-1)" "unprognostic (5.29e-2)" "unprognostic (3.70e-2)" "unprognostic (1.53e-2)" "unprognostic (2.43e-2)" "unprognostic (1.31e-1)" "unprognostic (1.20e-1)" "unprognostic (4.77e-2)" "unprognostic (4.41e-1)" "unprognostic (1.40e-2)" "unprognostic (2.60e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (1.16e-6)" "unprognostic (3.50e-2)" "unprognostic (2.68e-1)" "unprognostic (6.35e-2)" "unprognostic (6.20e-3)" 17.9 3.4 1.9 17.2 5.0 0.0 26.2 0.8 2.3 37.3 11.7 2.5 5.0 5.1 57.7 40.6 17.9 34.4 73.2 25.3 1.9 1.7 3.0 1.3 5.3 4.8 2.7 2.9 45.0 8.5 1.8 1.5 5.4 6.0 22.3 6.4 76.2 6.9 15.1 21.8 8.0 9.4 53.9 1.6 1.3 50.0 31.1 1.3 2.3 13.6 12.3 3.5 36.8 11.4 3.3 0.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 9.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.4 1.2 0.0 0.0 0.0 0.0 12.6 4.5 0.0 2.0 0.4 0.0 0.4 0.1 11.2 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 5.0 0.8 2.3 1.9 1.7 2.7 2.9 6.0 1.3 0.0 1.7 0.0 6.1 9.8 2.8 7.0 0.0 4.0 3.4 10.4 0.0 2.0 0.0 0.0 2.3 3.5 1.6 0.0 0.0 1.6 18.5 5.5 0.0 0.0 1.2 0.0 18.9 4.3 0.0 5.7 298.0 0.6 3.3 0.0 3.0 0.4 0.1 0.0 723.1 0.0 0.6 45.3 73.7 2.7 4.5 2.4 2.2 0.0 12.5 0.6 TINAGL1 "ARG1, LCN7, LIECG3, P3ECSL, TINAGRP" ENSG00000142910 "Tubulointerstitial nephritis antigen like 1" Q9GZM7 1 31576485-31587686 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.4" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 1103.3;Syncytiotrophoblasts: 1627.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 58.8;CAPAN-2: 32.1;EFO-21: 74.1;HaCaT: 32.2;HBEC3-KT: 37.9;HUVEC TERT2: 31.4;TIME: 67.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA048695 Approved "Secreted to extracellular matrix" NA NA 170000 "HPA048695: AB_2680497" "unprognostic (1.27e-1)" "unprognostic (2.94e-2)" "unprognostic (7.53e-2)" "unprognostic (1.80e-3)" "unprognostic (2.74e-1)" "unprognostic (1.72e-3)" "unprognostic (8.29e-3)" "unprognostic (6.02e-3)" "unprognostic (4.18e-1)" "unprognostic (6.96e-2)" "unprognostic (7.02e-3)" "unprognostic (1.22e-1)" "prognostic favorable (3.65e-6)" "unprognostic (7.42e-2)" "unprognostic (6.64e-2)" "prognostic favorable (9.64e-4)" "unprognostic (3.43e-2)" 43.0 8.4 2.2 11.6 3.4 0.8 60.0 0.8 4.4 30.2 22.0 2.9 14.2 12.0 25.7 23.4 23.7 17.0 36.1 52.6 3.4 2.3 53.3 14.7 24.4 12.8 3.9 3.3 15.5 7.4 3.2 5.6 128.4 5.0 19.4 7.9 12.0 24.2 20.0 19.6 7.6 15.9 22.5 2.7 34.3 16.3 10.3 2.1 0.8 30.7 11.0 6.4 39.8 20.0 1.1 0.6 4.8 0.5 1.5 0.8 0.0 16.7 0.0 0.0 0.1 0.1 0.0 58.8 2.6 0.3 0.1 0.0 7.9 32.1 0.0 74.1 2.3 1.2 32.2 0.0 37.9 0.0 0.1 0.0 0.0 1.4 2.0 0.8 0.0 0.1 0.0 6.9 0.0 1.4 0.0 31.4 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 9.1 1.0 0.0 0.0 0.0 10.2 12.9 0.0 0.1 6.8 22.7 0.7 3.6 1.3 0.0 67.1 0.0 17.0 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.6 4.8 0.5 0.5 0.8 0.3 0.5 0.4 0.6 0.5 0.1 1.1 0.8 0.8 2.7 1.5 0.5 0.6 0.5 0.0 2.2 3.4 0.8 4.4 3.4 2.3 3.9 3.3 5.0 2.1 8.9 7.2 5.3 91.5 9.7 0.0 41.9 38.2 1.4 7.9 125.6 0.0 1103.3 1.7 361.6 1.2 133.2 75.1 0.0 83.6 184.7 19.9 41.9 14.9 1.1 78.0 0.0 10.9 249.8 10.8 0.4 6.9 5.7 21.9 3.6 27.7 0.3 206.9 37.7 3.9 67.7 0.4 420.4 356.4 0.2 0.9 5.6 1627.5 6.4 49.2 157.0 TNN ENSG00000120332 "Tenascin N" Q9UQP3 1 175067858-175148066 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 15.2;gallbladder: 14.2" "Cell type enhanced" "Detected in some" 14 "Ito cells: 2.5;Smooth muscle cells: 2.7;Suprabasal keratinocytes: 1.6" "Cancer enhanced" "Detected in some" "breast cancer: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.6;NB-4: 4.7;THP-1: 14.4;U-266/70: 3.7;U-937: 2.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB010907, HPA026726, HPA026764" Uncertain "Secreted to extracellular matrix" NA NA 11000000 "CAB010907: AB_477565, HPA026726: AB_10601771, HPA026764: AB_10601859" "unprognostic (1.16e-3)" "unprognostic (2.23e-2)" "unprognostic (1.35e-1)" "unprognostic (2.21e-2)" "unprognostic (1.34e-1)" "unprognostic (1.48e-1)" "unprognostic (1.48e-1)" "unprognostic (3.55e-1)" "unprognostic (5.25e-3)" "unprognostic (1.01e-2)" "unprognostic (4.69e-1)" "unprognostic (5.07e-1)" "unprognostic (1.08e-3)" "unprognostic (1.76e-2)" "unprognostic (9.38e-3)" "unprognostic (1.89e-2)" "unprognostic (1.02e-2)" 15.2 0.2 0.1 1.5 0.2 0.0 7.9 0.4 0.8 0.3 0.8 0.1 0.1 1.0 0.1 0.5 0.3 0.0 14.2 0.6 0.1 0.0 0.4 1.8 1.8 0.1 0.1 0.9 0.1 0.3 1.8 3.7 0.1 0.6 0.1 0.1 4.8 6.4 0.1 0.1 5.3 1.0 0.8 0.7 0.6 0.5 0.1 0.3 0.3 2.6 7.5 0.3 0.1 0.2 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 14.4 0.0 0.0 0.0 0.0 0.0 3.7 0.6 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.7 0.1 0.0 0.1 0.9 0.6 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.7 1.6 0.1 0.0 0.0 0.0 UCMA C10orf49 ENSG00000165623 "Upper zone of growth plate and cartilage matrix associated" Q8WVF2 10 13221767-13234334 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 6.2;heart muscle: 3.2;ovary: 5.4;pituitary gland: 2.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Group enriched" "Detected in some" 6 "amygdala: 6.2;basal ganglia: 3.7;cerebral cortex: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.4;THP-1: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046718 Uncertain "Secreted to extracellular matrix" NA NA "HPA046718: AB_2679771" "unprognostic (4.25e-1)" 0.0 0.0 6.2 0.2 3.7 0.0 0.0 0.2 6.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 3.2 0.7 0.2 0.0 0.1 0.5 0.0 0.1 0.9 5.4 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 3.7 0.2 6.1 0.7 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 VWA1 "FLJ22215, VWA-1, WARP" ENSG00000179403 "Von Willebrand factor A domain containing 1" Q6PCB0 1 1434861-1442882 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 125.2" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 241.9;Syncytiotrophoblasts: 242.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 16.0;CACO-2: 16.2;CAPAN-2: 48.0;EFO-21: 15.4;Hep G2: 28.6;SCLC-21H: 17.0;T-47d: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA 190000 "unprognostic (2.78e-1)" "unprognostic (4.85e-2)" "unprognostic (5.91e-3)" "unprognostic (2.75e-1)" "unprognostic (2.67e-3)" "unprognostic (6.73e-2)" "unprognostic (9.52e-3)" "unprognostic (8.11e-2)" "unprognostic (1.18e-1)" "unprognostic (1.61e-1)" "unprognostic (3.47e-1)" "unprognostic (2.79e-2)" "unprognostic (3.13e-2)" "unprognostic (1.15e-1)" "unprognostic (1.69e-2)" "unprognostic (3.08e-2)" "unprognostic (6.71e-2)" 13.9 6.4 13.1 17.5 16.2 1.3 9.4 2.7 19.6 12.4 26.3 46.1 34.8 9.4 18.1 13.9 15.7 13.2 15.6 8.9 17.5 9.5 14.0 71.3 13.6 9.0 22.4 12.1 13.9 23.2 5.0 5.1 23.9 15.7 47.0 4.2 11.4 23.9 125.2 6.0 8.6 8.9 34.7 29.8 4.7 17.8 11.8 21.5 0.4 16.6 3.9 4.9 30.7 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 5.4 0.7 5.5 0.1 0.5 8.7 1.0 0.0 0.8 0.0 16.2 48.0 0.0 15.4 0.4 1.8 4.2 5.6 2.8 0.1 1.0 3.9 0.5 0.0 28.6 1.3 0.0 1.9 1.0 0.1 0.3 0.0 0.1 0.2 0.0 0.5 0.0 0.0 4.0 0.0 0.3 2.1 5.6 1.5 0.2 0.3 0.7 0.9 2.7 17.0 2.6 0.0 14.8 1.9 1.4 21.6 0.2 0.5 0.0 0.2 0.1 5.2 0.1 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 16.2 2.7 19.6 17.5 9.5 22.4 12.1 15.7 21.5 17.9 29.7 1.4 20.2 5.8 5.1 3.4 17.8 12.0 15.9 50.6 3.9 241.9 6.6 64.8 0.4 55.0 8.6 0.0 57.3 79.4 13.4 33.7 1.1 43.2 19.6 14.3 12.0 7.4 0.6 1.5 31.7 1.4 23.6 4.6 7.2 53.6 40.5 9.0 55.5 5.0 3.9 6.5 13.2 0.5 1.9 7.4 242.8 0.0 6.7 15.4 VWA2 "AMACO, CCSP-2, FLJ16213, FLJ45857, NET42" ENSG00000165816 "Von Willebrand factor A domain containing 2" Q5GFL6 10 114239330-114291513 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 16.3" "Group enriched" "Detected in some" 5 "Basal glandular cells: 3.7;Early spermatids: 9.8;Late spermatids: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 11.6;HaCaT: 5.5;SCLC-21H: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA037847 Uncertain "Secreted to extracellular matrix" NA NA "HPA037847: AB_10670961" "unprognostic (6.03e-2)" "unprognostic (8.29e-2)" "unprognostic (3.27e-2)" "unprognostic (7.33e-2)" "unprognostic (1.26e-2)" "unprognostic (6.82e-2)" "unprognostic (3.02e-2)" "unprognostic (9.33e-3)" "unprognostic (2.44e-1)" "unprognostic (3.70e-1)" "unprognostic (1.37e-3)" "unprognostic (3.14e-1)" "unprognostic (7.27e-3)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "unprognostic (9.30e-2)" "unprognostic (1.22e-1)" 0.7 0.2 1.5 2.2 1.8 0.4 3.9 1.0 3.2 5.3 2.0 2.1 3.6 2.5 1.4 14.3 5.5 10.8 2.6 0.3 2.2 1.6 1.0 0.3 8.4 0.4 4.1 1.7 2.3 6.0 0.1 4.1 0.6 2.4 7.4 1.1 0.1 16.3 1.6 0.4 6.7 2.1 0.1 2.3 1.6 12.4 2.3 2.2 1.2 0.8 1.3 1.5 2.1 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 11.6 0.0 0.4 0.0 0.0 5.5 0.0 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 3.3 0.0 0.0 0.9 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 1.8 1.0 3.2 2.2 1.6 4.1 1.7 2.4 2.2 0.0 0.0 0.0 3.7 0.2 0.0 0.4 0.0 0.0 0.0 1.8 0.0 1.2 0.0 1.6 9.8 0.0 0.0 0.0 1.4 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.0 0.3 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.6 0.0 0.1 1.1 VWC2 "PSST739, UNQ739" ENSG00000188730 "Von Willebrand factor C domain containing 2" Q2TAL6 7 49773661-49921950 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 17.0;heart muscle: 12.8;ovary: 12.5" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 26.4;Cardiomyocytes: 44.9;Paneth cells: 9.7;Rod photoreceptor cells: 12.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.4;U-266/70: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055243 Approved "Secreted to extracellular matrix" NA NA "HPA055243: AB_2682755" "unprognostic (3.30e-1)" "unprognostic (1.04e-1)" "unprognostic (8.90e-4)" "unprognostic (8.97e-2)" "unprognostic (8.77e-2)" "unprognostic (1.56e-3)" "unprognostic (3.41e-2)" "unprognostic (4.11e-1)" "unprognostic (6.65e-2)" "unprognostic (1.69e-4)" "unprognostic (1.60e-2)" "unprognostic (2.09e-2)" "unprognostic (1.52e-1)" "unprognostic (1.94e-1)" "unprognostic (9.70e-3)" 0.5 0.3 3.6 0.4 3.9 0.4 0.5 17.0 6.9 0.6 0.5 1.4 0.0 0.5 1.9 0.4 0.5 0.8 0.5 12.8 1.7 2.8 0.4 0.3 0.6 0.4 2.1 1.8 12.5 0.3 0.3 0.2 0.3 3.8 0.4 0.5 0.6 0.4 0.5 0.4 1.2 0.7 1.5 0.8 0.6 0.4 0.5 0.8 0.0 0.4 0.0 0.3 0.4 0.2 0.1 0.0 0.9 0.4 1.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.9 1.0 0.2 0.0 0.0 0.0 3.6 3.9 17.0 6.9 1.7 2.8 2.1 1.8 3.8 0.8 0.0 0.0 0.0 0.0 0.5 26.4 44.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 9.7 0.0 0.0 12.3 0.0 0.3 0.0 0.4 1.8 0.0 0.0 0.2 0.1